rfhg_168776.1

Basic information about the TSS

---

TSS ID: rfhg_168776.1 Species: human Chr: chr14		Start: 81220551 End: 81220580 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2743580,EH38E1731683)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: X77225:33 EU446618:33 EU446893:33 AB527745:33 GeneID: 2957 HGNC/MGI_ID: HGNC:4646 UniProt_ID: Nearer transcript ids and distances: LF359822:38 MA595399:38 LF329911:40 MA565488:40 X75383:-78 BC107155:-108 BC107156:-108 D14887:-342 ENST00000298173.7:-372 BC050703:-372 ENST00000553612.6:-379 NM_001278940.2:-379 NM_015859.4:-379 view more...

Gene_name: general transcription factor IIA subunit 1 Gene_symbol: GTF2A1 Gene_synonyms: TFIIA Gene_source: HGNC:4646

TATA-Box annotation

---

Distance to TSS:	394
Nearest PromoterID:	NM_001278940
Entrez ID:	2957
Nearest Unigene:	Hs.592334
Nearest Refseq:	NM_015859
Nearest Ensembl:	ENSG00000165417
Gene Name:	general transcription factor IIA subunit 1
Gene Alias:	TF2A1|TFIIA|TFIIA-42|TFIIAL
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.300000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GTF2A1 p2@GTF2A1 p3@GTF2A1 p4@GTF2A1 p5@GTF2A1 p6@GTF2A1 p7@GTF2A1 p9@GTF2A1 p10@GTF2A1
Sample		p1@GTF2A1	p2@GTF2A1	p3@GTF2A1	p4@GTF2A1	p5@GTF2A1	p6@GTF2A1	p7@GTF2A1	p9@GTF2A1	p10@GTF2A1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	26.69	10.91	4.09	0.19	2.34	0.19	1.36	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	26.91	9.71	3.84	0.40	2.02	0.20	2.02	0.40	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.62	9.26	6.17	0.00	2.51	0.19	1.93	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	26.40	6.65	2.70	0.00	1.87	0.00	2.08	0.62	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	25.87	8.77	3.82	0.00	1.80	0.22	3.82	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	25.20	9.69	1.94	0.19	1.55	0.19	2.33	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	27.24	12.42	4.14	0.87	1.74	0.00	3.05	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	23.50	10.42	5.81	0.48	1.70	0.00	1.45	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	25.22	8.33	2.78	0.64	1.28	0.21	2.35	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	55.64	10.43	7.54	0.00	1.74	0.58	2.32	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	52.15	12.94	5.66	0.40	0.00	0.00	4.45	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	54.88	13.01	7.32	0.81	1.63	0.81	3.66	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	8.54	11.93	2.42	0.00	0.00	0.48	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.07	6.92	1.95	0.60	0.15	0.30	0.30	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	8.34	6.81	1.32	0.00	0.44	0.00	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.30	5.28	3.02	0.50	0.50	0.50	0.25	1.01	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	5.90	6.12	1.75	0.66	0.22	0.22	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.70	9.28	1.69	0.42	0.00	0.00	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	5.33	8.00	1.60	0.00	0.00	0.53	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.63	8.12	2.26	0.45	0.30	0.75	0.60	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.83	8.95	2.94	0.40	0.27	0.53	0.13	0.40	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	7.42	10.70	2.42	0.17	0.35	0.69	0.17	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.14	6.08	2.07	0.00	0.13	0.13	0.39	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.41	5.10	1.70	0.00	0.00	0.00	0.49	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.58	10.06	1.03	0.26	0.00	0.26	0.26	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	6.65	7.28	3.17	0.63	0.32	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	8.79	6.04	1.65	0.00	0.00	0.00	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.55	10.61	3.30	0.24	0.00	0.00	0.47	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.01	5.49	1.78	0.97	0.16	0.32	0.65	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.85	7.24	1.45	0.18	0.00	0.18	0.00	0.54	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.70	4.81	2.51	0.63	0.42	0.42	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.62	5.28	2.15	0.20	0.00	0.00	0.00	0.59	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	6.96	6.96	1.27	0.42	0.00	0.21	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.58	5.61	2.64	0.16	0.33	0.16	0.66	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.66	6.17	2.24	0.19	0.75	0.00	0.56	0.00	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	10.54	4.60	3.07	0.19	0.38	0.19	0.00	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.01	6.34	2.86	0.41	0.20	0.00	0.61	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.07	4.43	2.22	0.60	0.00	0.20	0.20	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.10	3.78	1.35	0.27	0.54	0.00	0.27	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.48	5.04	1.92	0.48	0.00	0.24	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.76	4.47	1.65	0.24	0.00	0.00	0.24	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.37	7.17	3.37	0.44	0.00	0.00	0.73	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.97	5.91	3.80	0.63	0.00	0.42	0.63	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.01	8.04	2.10	0.70	0.17	0.17	0.00	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.05	7.63	1.41	1.00	0.40	0.20	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	11.40	6.28	2.79	2.09	0.47	0.00	0.47	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	5.76	6.72	3.36	0.00	0.00	0.00	0.48	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.05	7.75	2.68	0.30	0.60	0.00	0.00	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.34	8.86	2.15	0.24	0.00	0.00	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.11	5.66	3.64	0.81	0.61	0.61	0.40	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.35	8.20	1.64	0.20	0.41	0.20	0.41	0.61	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	14.68	8.01	2.45	0.44	0.44	0.22	0.22	0.89	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	83.95	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.42	5.32	2.84	0.00	0.00	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.60	6.96	2.32	0.66	0.33	0.00	0.00	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	6.71	6.71	0.84	0.84	0.00	0.84	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.73	7.81	5.97	0.00	0.46	0.00	0.00	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.96	4.86	3.57	0.00	0.65	0.00	0.00	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.56	3.21	1.93	0.00	0.00	0.00	0.32	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	12.26	7.86	6.29	0.00	1.26	0.00	0.63	0.31	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.05	5.64	2.82	0.00	0.00	0.00	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.65	4.49	2.24	0.56	0.56	0.00	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.15	11.15	7.96	0.80	2.39	0.80	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.91	7.14	2.04	0.00	0.34	0.00	0.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.65	5.85	1.30	0.97	0.00	0.32	0.65	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.00	6.39	2.13	0.35	0.35	0.00	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	32.33	48.49	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	7.90	39.49	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	6.34	5.85	4.88	0.00	0.49	0.49	0.49	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	7.93	3.47	1.98	0.50	0.50	0.50	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	6.10	0.94	0.00	0.94	0.00	0.00	1.41	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.59	5.30	3.64	0.33	0.33	0.00	0.33	1.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.35	4.95	2.17	0.00	0.62	0.00	0.62	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.95	6.42	2.75	0.31	0.31	0.00	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	13.62	8.39	4.28	0.95	1.11	0.63	0.79	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	9.14	8.18	3.85	1.28	0.16	0.00	0.64	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	15.78	10.56	4.07	0.64	0.76	0.64	1.53	0.25	0.13
Adipocyte - omental, donor2	11474-119C7	5.98	3.74	1.49	2.24	0.00	1.49	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	2.68	3.68	1.67	0.33	0.67	0.00	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	4.47	5.74	2.55	2.55	0.64	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	0.00	6.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	3.16	9.03	0.90	0.00	0.00	0.45	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	4.17	7.99	2.95	0.35	0.17	0.17	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	18.38	12.13	7.04	1.37	1.37	0.59	0.59	0.59	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	11.32	7.72	3.86	0.77	1.03	0.00	0.00	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	13.38	10.04	5.30	0.84	0.84	0.28	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	18.81	9.99	3.53	0.59	0.59	1.18	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	14.88	8.45	3.62	1.37	1.37	0.24	0.08	0.40	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	11.94	6.13	4.84	1.29	1.29	0.00	0.97	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	4.80	2.67	0.53	0.53	0.53	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.57	2.78	1.11	0.56	0.56	0.00	2.23	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	12.06	4.99	2.08	0.83	0.00	0.00	0.83	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.30	4.52	3.77	0.75	0.50	0.00	0.25	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	9.82	4.25	4.25	0.33	0.65	0.00	0.00	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	11.57	6.39	0.30	0.61	0.61	0.00	0.00	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	4.20	5.30	1.10	0.00	0.00	0.00	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	0.72	0.36	0.00	0.72	0.00	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	0.00	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	8.10	5.94	1.98	0.54	0.36	0.18	0.00	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	0.00	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.31	4.93	3.29	0.21	0.00	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	14.99	13.16	3.32	1.14	0.11	0.57	0.00	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	4.16	7.84	3.92	3.67	0.24	0.00	0.00	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	2.25	4.94	1.80	1.80	0.45	0.45	0.00	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	4.78	5.64	4.34	0.43	0.00	0.00	0.00	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	0.00	4.28	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	3.29	7.17	2.99	2.99	0.60	0.00	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	5.06	6.32	3.79	0.00	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.30	3.30	0.00	1.32	0.00	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	2.92	4.87	3.90	0.32	0.65	0.00	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	3.40	2.91	5.83	1.94	0.00	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	2.97	2.97	1.78	2.38	1.19	0.00	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	3.01	5.27	2.64	1.88	0.00	0.38	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	5.81	2.90	0.73	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	3.76	3.76	2.51	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.10	9.55	1.81	0.66	0.66	0.49	0.16	0.66	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	2.73	1.36	1.36	0.00	1.36	1.36	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.13	5.43	1.81	0.15	0.00	0.15	0.30	0.90	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	1.61	5.36	2.68	0.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	3.97	5.29	3.21	1.13	0.76	0.38	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	4.54	6.68	1.87	0.53	0.00	0.53	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	3.90	6.83	2.93	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.48	5.14	3.65	0.66	0.00	0.66	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	2.40	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	17.70	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4.97	7.03	2.57	2.57	0.69	0.17	0.34	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	2.43	3.40	3.40	0.49	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	1.90	7.97	2.28	3.04	0.00	0.00	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	8.48	2.42	1.21	0.00	1.21	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	2.85	6.84	6.27	1.14	0.00	0.00	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	2.35	9.41	3.63	2.14	0.43	0.21	0.00	1.28	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.16	5.94	1.29	1.29	0.00	0.26	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	1.88	6.57	4.22	0.94	0.47	0.00	0.47	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.50	6.11	3.22	2.25	0.32	0.00	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.85	1.43	0.71	1.43	0.00	0.71	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	2.92	7.60	2.92	0.00	0.58	0.58	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	3.01	6.92	2.71	3.01	0.30	0.30	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	1.19	9.50	3.56	1.19	0.00	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.58	4.07	4.07	0.51	0.00	0.51	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	4.08	7.13	3.82	1.02	0.51	0.00	0.25	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.81	1.91	1.91	0.64	0.64	0.64	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	1.73	6.90	3.88	0.86	0.00	0.43	0.00	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.66	6.77	2.33	1.69	0.21	0.00	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.93	5.80	1.45	0.29	0.00	0.58	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	6.61	6.61	1.89	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	5.42	6.44	2.71	2.54	0.00	0.17	0.17	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	13.90	0.00	2.32	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	2.11	4.23	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.29	5.57	3.22	1.93	0.43	0.00	0.64	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.01	4.81	1.80	1.20	0.00	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	2.92	0.73	0.00	0.00	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	4.14	6.67	2.07	1.38	0.00	0.23	0.23	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	2.55	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	10.93	8.14	1.78	0.25	0.25	0.25	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	4.13	8.67	3.30	0.83	0.21	0.62	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.28	6.43	3.37	1.53	0.31	0.31	0.31	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5.74	5.74	5.26	0.00	0.48	0.00	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5.10	6.43	3.10	2.00	0.00	0.22	0.22	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	7.63	4.58	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	3.88	6.09	3.88	2.22	0.00	0.55	0.00	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	3.71	4.77	4.77	1.06	0.26	0.26	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.82	3.27	3.27	1.45	0.36	0.36	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	4.05	4.79	3.81	1.97	0.49	0.12	0.12	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	1.88	4.45	1.54	0.34	0.17	0.00	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	4.19	5.24	1.68	0.21	0.00	0.00	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	18.82	15.34	5.58	2.09	0.70	1.39	0.70	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	21.84	16.34	9.38	2.59	1.13	1.29	0.32	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	20.73	22.67	5.22	1.79	1.94	1.04	0.30	0.30	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	10.55	32.80	3.90	2.18	1.83	1.61	0.57	0.23	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	12.90	33.07	4.26	3.38	1.63	0.88	0.75	0.38	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	10.36	28.79	5.12	2.62	1.59	1.02	0.91	0.46	0.11
Basophils, donor1	12241-129G9	21.71	1.57	2.09	0.52	1.05	0.26	1.57	0.52	0.26
Basophils, donor2	12242-129H1	21.65	5.41	2.53	0.72	1.08	0.36	4.69	0.36	0.00
Basophils, donor3	12243-129H2	19.70	2.50	4.85	0.73	1.47	0.00	1.03	0.44	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	1.08	2.59	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.46	1.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	21.52	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2.51	0.63	1.26	0.63	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	1.46	1.87	0.62	0.62	0.00	0.00	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	1.84	2.53	1.15	0.92	0.23	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	3.06	6.84	1.08	1.08	0.36	0.18	0.00	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	31.23	21.02	5.46	1.44	0.93	0.82	0.10	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	27.48	14.67	4.66	1.40	0.93	0.93	0.00	0.23	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	38.05	10.87	4.16	1.28	1.28	0.00	0.32	1.60	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	61.43	1.13	11.27	0.00	1.69	0.00	1.69	2.25	0.56
CD14+ Monocytes, donor2	11305-117B9	45.66	1.30	9.65	0.93	0.93	0.00	1.86	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	84.08	4.39	4.17	0.88	0.00	0.00	1.54	0.88	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	20.66	7.64	6.23	2.26	1.42	0.57	0.28	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	30.71	16.30	4.93	0.38	0.38	0.76	1.14	0.76	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	34.85	14.46	4.93	0.99	1.64	0.33	0.66	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	42.06	14.60	11.27	2.02	1.88	0.43	1.30	1.30	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	45.56	4.53	12.67	0.91	2.72	0.30	1.81	0.00	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	57.09	11.37	6.87	0.71	0.71	0.00	1.90	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	55.07	8.04	13.73	1.17	0.50	0.33	1.84	0.50	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	65.41	6.07	16.56	2.48	1.66	0.00	2.21	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	113.55	9.17	20.33	1.49	2.23	0.25	4.71	1.24	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	40.14	6.66	7.05	0.78	1.37	0.00	1.96	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	44.87	6.23	13.53	1.42	1.60	0.36	1.25	0.53	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	78.56	6.31	4.57	0.65	3.48	0.22	2.61	1.09	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	140.94	7.73	32.08	3.98	1.17	0.23	2.58	1.64	2.34
CD14+ monocytes - treated with Candida, donor2	11878-125C6	130.42	8.45	36.96	3.17	3.17	0.00	3.70	1.58	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	194.14	6.66	29.95	5.55	1.11	0.00	6.66	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	41.35	9.82	10.26	1.49	0.89	0.15	0.89	0.45	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	49.49	6.39	9.98	0.80	1.40	0.00	2.20	0.80	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	70.58	8.95	5.41	0.42	1.87	0.21	2.08	0.83	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	80.30	4.12	23.11	3.66	1.83	0.23	1.37	1.83	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	81.66	7.01	6.11	0.23	1.36	0.00	2.71	1.58	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	127.88	5.67	20.08	2.18	1.31	0.00	4.36	0.00	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	26.09	6.46	9.15	0.54	0.81	0.27	1.34	1.08	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	38.38	6.98	10.12	1.92	1.05	0.17	1.40	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	29.88	6.31	6.73	0.84	1.68	0.42	0.84	1.26	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	47.03	6.43	9.55	1.84	1.47	0.00	2.02	1.29	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	74.33	2.82	12.33	1.41	1.76	0.00	3.52	1.41	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	77.65	5.70	13.60	2.19	3.95	0.00	1.75	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	61.55	9.42	12.55	2.96	1.57	0.00	1.39	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	52.41	5.58	10.78	1.12	1.49	0.00	1.49	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	91.18	8.62	5.17	1.08	4.53	0.00	5.39	2.59	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	54.05	7.78	11.47	0.41	0.41	0.00	1.23	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	73.02	3.48	5.79	0.00	2.55	0.00	3.48	0.93	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	109.96	4.18	4.87	1.39	2.55	0.00	3.48	1.16	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	19.40	6.54	1.96	0.00	1.09	1.09	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	27.03	6.47	4.85	0.92	0.00	0.00	0.46	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	23.61	5.42	3.90	0.43	0.22	0.43	0.87	0.87	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	23.98	11.37	3.11	0.78	1.25	0.47	1.09	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	16.94	6.64	5.94	0.70	0.70	0.35	0.52	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	19.18	8.92	1.11	0.00	0.67	0.45	1.78	1.56	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	20.67	11.99	4.08	0.00	0.26	0.51	1.02	1.02	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	17.13	5.93	5.49	0.22	0.66	0.22	0.22	1.32	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	25.05	8.00	1.89	0.21	0.84	0.21	0.42	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	8.13	6.10	2.03	2.03	0.00	2.03	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	46.10	26.44	12.20	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	46.60	18.64	17.61	2.07	1.04	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	45.84	26.65	13.33	1.60	1.07	0.00	0.00	2.13	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	58.97	25.20	12.87	1.61	0.54	0.00	0.54	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	61.07	18.95	8.42	3.51	0.00	0.70	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	50.98	24.31	14.12	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	79.10	17.14	11.86	1.32	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	55.89	4.93	12.33	4.93	3.29	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	36.27	3.63	8.71	0.00	1.45	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	41.40	9.59	8.08	0.50	2.02	0.50	3.03	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	60.61	31.11	7.27	1.21	0.81	0.00	1.21	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	54.33	21.57	3.99	0.40	0.40	0.00	1.60	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	11.04	2.01	4.02	0.00	4.02	0.00	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	17.98	3.37	3.93	3.93	1.12	0.00	1.69	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	21.42	11.27	7.89	1.13	0.38	0.38	0.75	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	25.25	9.92	4.74	0.68	1.35	0.45	0.90	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	39.63	12.50	6.78	1.43	3.57	0.00	1.43	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	53.28	7.35	15.92	2.45	6.12	0.00	2.45	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	108.27	12.50	6.10	1.22	6.10	0.00	2.13	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	25.52	13.27	9.44	1.28	1.53	0.26	0.26	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	46.27	15.27	7.86	2.02	1.35	0.67	0.00	0.45	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	42.26	16.10	5.17	0.86	1.44	0.86	0.29	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	42.19	18.02	8.53	0.00	4.27	0.95	2.37	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	42.14	11.94	12.64	0.00	0.70	0.70	2.81	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	26.37	3.30	0.00	0.00	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	20.67	10.12	5.64	0.43	1.01	0.43	0.43	0.43	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	25.93	10.68	11.02	3.73	1.19	0.34	0.17	0.68	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	23.05	13.22	6.93	2.42	0.97	0.16	0.32	0.32	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	39.90	4.03	15.24	0.45	1.79	0.00	1.79	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	43.67	4.19	12.23	2.45	1.05	0.00	1.75	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	54.12	14.08	3.96	0.00	3.96	0.44	1.32	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	22.77	8.43	4.22	0.00	2.11	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	25.56	10.60	6.23	2.08	1.87	0.21	0.42	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	31.07	11.36	7.68	2.00	2.34	0.00	0.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	44.05	22.84	11.42	0.27	5.17	0.27	1.36	1.36	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	38.05	12.86	12.33	1.07	2.68	0.00	1.61	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	28.69	7.17	7.17	1.79	3.59	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	28.19	11.13	6.86	1.30	2.60	0.37	0.93	0.37	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	32.28	11.26	7.58	0.87	1.30	0.87	0.65	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	38.25	11.98	5.88	1.47	2.31	0.84	0.84	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	51.57	13.15	14.66	0.00	6.57	0.00	4.55	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	52.42	8.67	12.13	1.30	3.90	0.00	1.30	0.43	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	51.86	14.38	4.36	0.87	6.10	0.00	1.74	1.74	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	43.55	28.70	10.39	3.46	2.97	0.00	0.49	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	29.54	25.85	9.23	0.00	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	53.04	15.35	8.37	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	20.22	15.78	8.86	4.15	3.60	0.00	1.66	1.11	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	16.44	19.88	8.10	6.87	4.17	0.25	0.25	0.98	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	41.58	27.72	9.24	0.00	3.08	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	35.10	30.80	7.88	1.07	1.43	0.36	0.72	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	58.17	27.70	9.69	1.38	1.38	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	60.24	6.22	9.17	0.33	7.20	0.00	4.26	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	73.21	3.00	18.02	4.13	2.25	0.00	3.75	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	93.67	15.91	7.57	1.26	2.02	0.25	1.26	0.76	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	15.14	5.96	3.21	0.00	0.46	0.69	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	12.22	7.91	1.68	0.00	0.00	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.42	9.03	0.00	0.27	0.55	0.27	0.00	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	16.81	8.11	2.40	1.20	1.20	0.00	0.30	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	19.20	5.28	2.64	0.24	0.48	0.48	0.24	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	17.28	6.37	3.18	0.23	0.68	0.23	0.45	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.34	5.87	2.39	0.43	0.65	0.00	0.43	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.00	5.00	0.79	0.53	0.79	0.00	1.05	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	16.18	7.74	1.88	0.70	0.94	0.23	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	19.02	6.64	1.81	0.60	1.21	0.00	0.00	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	14.82	7.84	0.87	0.00	0.58	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	17.32	8.79	1.07	0.00	0.53	0.27	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	35.46	6.13	3.06	0.00	1.75	0.44	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	42.81	7.74	4.55	0.00	0.46	0.00	0.91	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	46.99	5.97	5.97	0.00	0.75	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.85	6.12	1.44	0.36	1.08	0.36	1.08	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.40	10.07	2.01	0.29	0.29	0.29	0.00	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.32	6.13	1.65	0.47	1.65	0.47	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	13.31	8.24	0.95	0.32	0.32	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.68	7.07	3.38	0.31	1.54	0.31	0.31	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	17.31	6.41	2.24	0.00	0.64	0.32	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	18.74	8.41	2.68	0.38	0.38	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	18.13	7.88	1.58	0.79	0.79	0.39	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	19.67	11.35	2.27	0.00	0.76	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	89.13	17.67	12.04	1.61	1.61	0.00	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	100.02	18.88	9.09	0.00	2.10	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	81.14	21.04	9.02	0.00	0.00	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	9.14	3.66	3.66	1.83	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	11.36	5.93	3.95	0.99	0.00	0.00	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	6.31	9.16	2.00	1.26	0.32	0.00	0.00	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	9.36	8.67	4.16	3.12	0.69	0.69	0.35	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	6.40	5.33	3.20	0.00	0.71	0.71	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	13.31	11.49	2.62	0.91	0.11	0.68	0.46	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	14.32	13.43	5.37	0.00	2.69	0.90	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	16.98	16.98	3.24	0.40	0.40	0.00	0.00	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	18.02	18.94	6.31	1.49	0.34	0.57	0.57	0.46	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	8.34	13.04	9.62	1.71	0.43	0.21	0.21	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	15.13	15.93	4.07	0.53	0.18	0.62	0.27	0.18	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	25.22	23.84	6.88	1.01	1.19	1.93	0.46	0.92	0.00
Corneal Epithelial Cells, donor1	11526-119I5	1.54	2.85	0.22	0.22	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	9.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	2.30	3.07	2.30	0.77	0.00	0.00	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	18.66	8.25	9.08	0.66	1.32	0.17	0.50	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.03	10.09	5.36	2.52	0.32	0.32	0.95	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	10.35	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	16.85	9.83	2.59	0.76	0.65	0.32	0.43	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	24.94	6.49	4.10	0.68	5.81	0.00	0.68	1.37	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	31.34	2.61	4.57	0.00	8.49	0.65	3.92	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.45	6.29	5.81	3.87	7.26	0.00	5.32	3.87	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	10.01	7.67	2.50	0.33	0.83	0.33	0.17	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	2.93	2.35	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	4.81	2.83	1.13	0.00	0.57	0.28	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	10.22	6.68	1.18	0.00	0.00	0.00	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	2.33	3.20	1.45	0.58	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	8.94	6.82	1.65	0.71	0.47	0.47	0.00	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	6.84	9.29	1.23	0.18	0.35	0.00	0.35	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	5.98	7.31	1.77	0.44	0.22	0.44	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	8.82	16.43	2.43	0.30	0.61	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	12.97	12.40	3.66	0.00	1.13	0.00	0.28	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	3.86	3.27	2.38	3.27	0.89	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	8.33	6.25	2.08	0.52	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	9.22	5.96	1.28	0.14	0.14	0.00	0.00	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	7.20	2.00	3.60	3.20	0.80	0.00	1.20	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	1.05	4.19	0.00	0.52	0.00	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	11.31	18.51	3.85	1.24	1.74	0.50	0.12	0.00	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	9.99	11.08	4.13	0.87	1.09	0.43	0.22	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	12.70	12.58	2.44	1.10	0.73	0.37	0.24	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	7.96	1.14	4.55	0.00	0.00	0.00	0.00	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	5.59	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	7.54	3.93	1.26	0.31	0.16	0.16	0.00	0.47	0.00
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	39.61	37.96	4.95	0.00	1.65	0.00	6.60	1.65	0.00
Eosinophils, donor3	12246-129H5	64.20	21.40	0.00	0.00	3.57	0.00	0.00	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	0.73	3.42	1.47	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	4.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	18.06	9.85	2.87	1.64	0.82	0.82	1.64	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.05	4.93	1.53	0.11	0.33	0.11	0.00	0.22	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.94	7.91	3.25	0.22	0.43	0.33	0.33	0.11	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	10.31	8.49	3.52	1.33	0.49	0.49	0.24	0.24	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	10.24	12.69	2.73	1.09	0.27	0.55	0.55	0.41	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.33	8.33	4.11	0.74	0.21	0.21	0.32	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	2.63	5.01	2.11	2.11	0.26	0.79	1.05	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	13.62	18.27	2.33	0.33	0.33	1.33	1.00	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	4.99	5.90	1.81	1.81	0.00	0.00	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.06	2.27	2.27	0.00	0.00	0.00	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	4.57	5.52	0.79	0.32	0.47	0.47	0.00	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	16.37	21.82	5.76	0.61	0.30	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	6.35	6.73	3.05	2.54	1.02	0.13	0.00	0.25	0.00
Fibroblast - Cardiac, donor6	11460-119B2	4.55	5.46	3.03	1.97	0.45	0.61	0.15	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	2.95	4.56	4.15	1.74	0.27	0.00	0.27	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.92	4.31	6.90	0.43	0.00	0.00	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	7.32	13.18	2.93	0.00	0.00	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.07	12.92	2.31	0.23	0.23	0.23	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	13.40	8.99	2.88	0.85	0.68	0.34	0.17	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	2.11	7.98	2.35	0.70	0.00	0.94	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	3.77	5.66	2.36	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	6.53	13.06	0.73	0.24	0.24	0.36	0.00	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	3.50	8.37	4.63	1.81	0.34	0.45	0.11	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	4.71	9.25	4.36	2.97	0.52	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	4.87	11.53	5.04	3.57	0.65	0.49	0.49	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	9.16	18.12	3.12	0.42	0.62	0.21	0.00	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	7.07	19.13	3.93	2.36	1.31	0.79	0.52	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	8.57	20.16	6.33	1.32	0.66	0.79	0.26	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	21.85	24.46	2.61	0.29	0.58	0.77	0.00	0.58	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	10.39	10.39	0.00	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.04	12.33	4.76	0.53	0.70	0.53	0.00	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	12.63	15.59	3.59	2.18	0.94	0.78	0.62	0.78	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	9.20	12.04	3.52	1.22	0.54	0.14	0.54	0.54	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.23	18.00	5.65	0.71	1.06	0.71	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	11.85	12.58	3.36	0.73	0.58	0.44	0.15	0.00	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	11.18	9.41	5.32	1.77	0.68	0.27	1.09	0.68	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	11.96	9.98	6.91	0.99	1.32	0.11	0.99	0.55	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	19.37	13.65	3.67	1.17	0.73	0.29	0.15	0.15	0.44
Fibroblast - Lung, donor1	11270-116H1	5.44	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	23.87	0.00	0.00	2.98	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	10.34	16.67	1.90	0.63	0.21	0.42	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	1.67	7.50	1.67	1.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	1.40	2.80	2.80	0.00	1.40	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.56	2.24	0.28	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	7.31	17.05	2.84	0.41	0.00	0.41	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	8.53	21.53	2.72	0.39	0.19	0.78	0.00	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.38	22.30	6.83	1.37	0.15	0.30	0.30	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	11.93	26.31	3.06	0.92	1.22	0.61	0.00	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	7.63	8.78	2.29	1.91	0.76	0.38	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	6.48	10.53	3.78	2.43	1.08	0.27	1.08	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.05	13.34	1.86	0.58	0.46	0.35	0.00	0.23	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	10.83	8.62	1.22	0.66	0.66	0.44	0.44	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.50	10.16	2.24	0.20	0.20	0.41	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.00	8.69	2.00	0.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	6.72	8.70	2.37	0.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	4.76	7.14	3.57	3.57	0.60	0.79	1.19	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.92	10.48	3.02	0.00	0.89	0.00	0.18	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	12.22	10.45	1.77	0.79	0.79	0.39	0.59	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	4.81	7.22	4.51	3.01	1.50	0.30	0.30	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	7.66	11.23	3.35	2.59	0.97	0.43	0.76	0.76	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	3.29	7.34	4.56	3.04	1.27	0.76	0.25	1.01	0.00
Fibroblast - skin normal, donor1	11553-120C5	10.01	9.02	3.12	0.82	0.16	0.16	0.33	0.82	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	13.83	19.45	2.81	2.01	2.61	0.00	0.40	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	7.13	9.64	2.51	2.81	1.61	0.70	0.90	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	8.16	6.95	3.63	3.32	0.91	0.30	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	13.34	12.26	4.14	0.75	0.66	0.41	0.41	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	6.15	5.98	4.62	4.79	0.85	0.17	0.34	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	2.96	4.93	0.99	3.28	1.31	1.31	0.33	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	6.28	8.20	2.88	2.88	2.02	0.21	0.85	0.43	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	9.95	8.94	3.20	0.84	1.18	0.17	0.84	0.51	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	7.06	8.63	1.10	0.63	0.47	0.31	0.63	0.16	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	44.32	0.00	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	16.56	10.46	3.49	0.87	0.87	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.63	9.71	2.60	0.35	0.17	0.35	0.52	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.33	10.93	1.56	0.26	0.26	0.52	0.78	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	6.64	14.82	2.30	0.26	0.77	0.26	1.02	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	35.22	13.01	3.83	0.00	1.53	0.77	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	28.08	8.29	10.21	1.28	1.28	0.00	1.28	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	57.62	46.50	15.40	3.42	2.57	3.14	1.43	0.57	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	45.78	57.91	15.99	1.65	0.55	2.48	0.00	0.28	3.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	93.61	25.80	13.01	0.91	0.68	2.28	0.46	0.68	4.79
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	42.80	33.09	10.50	1.59	0.99	1.39	0.59	0.59	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	45.99	48.37	12.42	1.59	1.32	2.11	0.00	0.00	2.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	118.39	19.57	18.26	1.30	0.98	0.98	0.65	0.65	5.54
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	45.55	42.90	13.27	2.21	1.77	2.65	0.44	1.33	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	13.57	20.92	6.78	2.12	0.42	0.57	0.14	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	11.21	17.12	6.40	1.72	0.86	0.62	0.25	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	15.31	13.97	6.18	1.88	0.81	0.81	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	11.27	16.11	3.59	0.74	0.25	0.74	0.62	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	8.72	17.58	3.88	0.69	1.11	0.69	0.00	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	9.96	18.70	4.27	1.22	0.61	1.02	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	11.41	12.09	8.44	1.37	0.46	0.91	0.68	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	6.85	14.33	2.12	0.50	1.37	0.37	0.62	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	4.37	15.96	3.72	1.31	0.87	0.87	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.30	8.27	4.73	2.66	0.89	0.30	0.30	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	12.24	16.21	4.45	1.11	0.64	1.43	1.11	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	7.15	11.39	3.13	1.12	0.22	0.45	0.45	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	12.50	14.52	8.27	1.61	0.60	0.20	0.60	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.08	13.06	6.11	0.68	0.68	0.51	0.34	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	18.44	14.99	7.09	0.44	1.51	0.80	0.80	0.18	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.75	14.67	6.66	0.21	0.94	0.52	0.52	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.25	9.39	4.61	0.85	2.05	0.51	0.85	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	13.83	14.50	3.54	1.22	0.55	0.55	0.11	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.97	13.98	5.16	0.67	1.41	0.67	0.83	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.44	12.05	3.68	0.41	2.25	0.41	0.61	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	12.17	11.76	4.33	1.86	0.62	0.62	0.21	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	13.14	13.72	4.84	1.15	0.58	0.35	0.58	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	15.68	13.67	5.67	2.33	0.83	0.50	0.50	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	13.23	11.68	2.20	1.10	0.22	0.00	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	13.04	12.42	4.06	1.11	0.61	0.61	0.61	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	14.75	14.59	5.67	0.81	0.65	0.16	1.13	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	12.83	15.39	5.45	1.60	0.96	0.96	0.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	11.28	13.08	3.51	0.85	0.57	0.38	0.09	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	14.55	8.54	6.17	1.27	0.00	0.16	1.11	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	10.95	8.82	3.04	0.61	0.61	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.77	13.49	6.27	1.36	0.31	0.52	0.21	0.10	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	14.49	13.39	3.29	1.32	0.00	0.00	0.66	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	18.24	16.55	6.73	1.12	0.84	0.00	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.67	8.15	3.80	0.65	0.56	0.28	0.19	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	13.64	8.29	2.67	1.87	1.34	0.00	0.80	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	15.61	11.02	5.05	0.77	1.07	0.77	0.31	0.61	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	11.92	10.10	3.63	1.04	0.39	0.52	0.52	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	15.45	11.93	4.88	0.54	0.81	0.54	0.54	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	14.38	11.61	4.06	0.74	0.18	0.37	0.92	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	11.40	12.50	3.95	1.32	0.44	0.22	1.10	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	19.83	24.79	4.96	1.98	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	10.55	9.10	3.83	0.92	0.92	0.40	0.00	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	10.09	11.50	3.03	0.40	0.40	0.00	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	19.32	16.52	4.07	0.51	0.76	0.25	0.51	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	10.35	16.32	7.37	6.97	2.39	0.60	0.20	0.20	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	14.64	28.66	9.24	1.39	0.62	0.77	0.00	0.31	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	22.09	24.14	8.18	1.23	1.43	1.02	0.61	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	23.47	10.33	5.95	1.56	0.31	0.63	0.31	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	16.67	11.58	6.22	1.70	0.85	0.00	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	15.22	18.91	11.07	3.69	0.00	0.46	0.92	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	34.65	19.80	2.47	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	29.40	14.31	13.15	2.71	1.16	1.16	0.77	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	25.67	25.67	12.84	1.60	1.60	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	12.17	8.69	3.48	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.67	13.67	12.69	4.88	0.33	0.33	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	17.30	12.77	6.59	3.71	2.06	0.82	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	13.33	10.00	3.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	22.93	6.43	7.83	1.12	0.00	0.84	0.00	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	22.23	7.84	10.46	3.60	0.33	0.33	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	24.33	14.26	10.07	2.52	1.68	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	17.18	12.09	7.00	0.95	0.64	0.32	0.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	19.02	11.55	8.83	1.70	1.02	0.68	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	20.88	10.44	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	9.16	9.74	7.45	1.72	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.02	8.88	5.92	1.78	0.00	0.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	10.16	6.78	6.78	0.00	0.00	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	16.98	11.60	7.04	2.07	0.41	0.41	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	23.01	12.43	9.44	3.45	0.00	0.23	0.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	10.54	5.27	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	12.69	11.92	12.30	2.69	0.77	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	17.93	8.48	9.45	0.65	0.00	0.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	23.41	5.35	7.36	0.00	0.00	1.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	17.34	10.79	10.40	3.47	0.39	0.39	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	22.25	9.59	11.30	0.34	0.34	0.34	0.00	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	24.85	14.91	2.48	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	11.80	16.51	5.19	1.42	0.00	0.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	18.10	10.26	2.41	0.60	0.00	0.60	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	17.29	9.16	8.14	0.51	0.51	0.00	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	20.34	9.97	5.98	2.79	0.40	0.80	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	13.81	9.37	9.87	1.97	0.99	0.49	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	17.71	10.62	11.80	3.54	1.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	14.00	15.17	9.34	2.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	13.17	13.17	10.97	1.32	0.00	0.00	0.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.04	12.72	4.24	1.70	0.85	0.85	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.34	6.57	6.57	0.60	0.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.98	4.37	5.82	1.46	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	9.13	4.57	0.00	0.00	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.89	4.57	3.74	1.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	12.37	1.12	1.12	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	12.69	13.00	3.49	1.27	0.63	0.32	0.00	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.52	6.27	4.18	0.84	0.00	0.42	0.00	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.85	11.14	4.18	1.04	0.81	0.35	0.35	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	17.39	9.62	5.40	0.68	1.01	0.17	0.17	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	13.65	13.88	3.19	0.68	1.59	0.00	0.68	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.54	11.91	5.68	1.20	0.77	0.44	0.22	0.33	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	14.83	7.74	5.37	1.29	0.43	0.21	0.43	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	13.78	7.32	3.88	0.43	0.43	0.22	0.22	0.43	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	8.59	8.22	2.99	0.50	0.25	0.37	0.25	0.12	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.18	6.00	2.40	0.17	0.51	0.00	0.17	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.89	5.77	1.92	0.32	0.96	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.36	3.36	2.24	1.68	0.00	0.00	0.56	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	2.60	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	10.58	0.00	2.64	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.29	6.00	0.71	0.35	0.71	1.06	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	3.63	0.73	0.00	0.00	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.79	6.29	1.92	1.57	1.22	0.35	0.52	0.00	0.00
Hepatocyte, donor1	11523-119I2	16.95	9.68	2.42	1.21	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	9.70	7.54	4.31	0.00	2.15	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	15.34	11.66	3.68	0.61	0.61	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	49.60	8.48	15.01	0.65	1.96	0.65	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	20.45	9.09	2.45	0.70	2.62	0.17	0.52	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.76	8.92	1.78	0.82	0.14	0.00	0.00	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	12.74	3.18	0.00	0.00	0.00	9.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	6.68	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	20.77	5.54	5.54	0.00	0.00	0.00	2.77	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	2.50	0.00	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	2.56	5.13	0.00	0.00	0.00	2.56	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	9.14	0.00	0.00	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	11.37	4.87	1.62	1.62	0.00	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	6.67	5.00	0.00	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	11.91	3.97	0.00	1.32	0.00	2.65	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	7.76	4.43	1.11	0.00	3.33	0.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	10.71	2.52	0.00	2.52	1.26	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	9.28	4.64	1.55	0.00	0.00	4.64	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	7.75	7.11	2.58	0.00	3.88	0.00	7.75	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	6.44	6.44	3.22	4.83	0.00	4.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00	11.95	0.00	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	12.22	0.00	0.81	1.63	0.81	0.81	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.24	11.33	2.10	0.00	2.10	0.84	1.68	1.68	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	9.64	8.84	2.41	0.00	2.41	0.80	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	10.16	4.62	1.85	1.85	2.77	0.00	2.77	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.72	6.14	1.89	0.00	2.36	0.00	1.42	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	3.63	0.00	0.00	0.91	0.00	3.63	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	7.53	10.76	2.15	0.00	4.30	0.00	2.15	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	17.79	15.25	0.00	0.00	5.08	0.00	3.81	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.74	7.65	1.91	0.00	3.19	0.64	1.91	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	3.65	0.00	0.00	0.00	1.82	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.71	14.28	2.14	0.00	2.14	0.71	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	3.32	3.32	0.00	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.56	8.03	1.23	0.93	1.54	0.31	1.85	0.93	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	3.51	0.00	0.00	3.51	0.00	1.76	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	6.29	0.00	0.00	12.57	0.00	3.14	6.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.87	9.04	4.17	0.00	3.48	0.70	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	8.85	0.00	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	12.97	9.73	0.00	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4.36	15.69	2.62	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	4.50	2.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	6.40	2.13	1.07	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	9.70	4.16	0.00	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	14.25	0.00	0.00	5.70	0.00	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	9.20	2.76	0.00	2.76	0.00	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	9.52	4.23	0.00	1.06	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	4.57	5.96	2.69	0.49	0.24	0.16	0.16	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	0.59	1.76	1.76	0.59	0.59	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	9.37	12.78	1.80	0.09	0.47	0.09	0.19	0.38	0.00
Keratinocyte - oral, donor1	11251-116E9	7.83	18.39	1.48	0.68	0.11	0.45	0.23	0.23	0.00
Keratocytes, donor1	11527-119I6	8.94	10.66	4.13	0.00	0.69	0.69	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	2.34	5.86	2.34	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	7.71	10.87	2.57	0.59	0.59	0.20	0.59	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	10.99	0.00	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	6.47	10.79	1.08	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	11.76	9.69	4.04	1.04	0.46	0.35	0.00	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	12.21	16.55	4.04	1.21	0.50	0.20	0.40	0.20	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.59	6.05	0.95	0.36	0.24	0.12	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.91	3.63	2.23	0.56	0.56	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.65	8.19	5.67	1.10	1.42	0.16	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	2.69	3.76	1.61	2.69	1.08	0.54	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.67	2.52	2.84	0.32	0.32	0.32	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.85	2.48	1.29	0.43	0.22	0.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	8.21	3.69	3.69	0.82	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.78	1.01	0.76	0.00	0.25	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5.07	3.80	2.39	0.99	0.28	0.14	0.00	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.93	5.14	4.35	1.19	1.19	0.00	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.01	3.49	4.07	0.00	0.58	0.00	0.39	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.96	1.11	1.85	0.19	0.00	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.62	6.27	1.74	0.35	0.35	0.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.01	4.53	1.91	0.95	0.24	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	3.43	2.06	1.24	0.27	0.55	0.14	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	7.39	8.01	1.23	0.92	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.12	3.74	1.56	0.62	0.31	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	3.11	2.20	1.46	0.37	0.55	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.57	4.28	0.66	0.99	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	1.76	1.46	1.17	0.29	0.59	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	2.99	1.99	1.24	2.99	0.00	0.75	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.24	4.85	0.97	0.48	0.97	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.73	2.69	4.04	0.54	1.08	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.66	3.63	1.51	0.45	0.61	0.15	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.33	3.63	1.56	0.52	0.52	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.54	5.23	4.40	0.21	0.21	0.00	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.21	2.26	1.95	1.05	0.15	0.30	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.94	7.57	4.82	0.69	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.01	4.33	2.63	0.56	0.38	0.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.18	2.01	1.17	0.21	0.32	0.11	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	6.78	1.94	0.97	0.00	0.97	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.96	4.63	4.30	0.00	1.32	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.85	2.60	1.49	0.62	0.50	0.12	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.89	7.77	2.22	0.74	0.37	1.11	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.95	4.45	2.96	0.49	0.00	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.47	2.75	1.79	0.27	0.69	0.14	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.01	8.68	3.54	1.61	0.32	0.64	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	9.43	8.52	5.48	0.61	0.61	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.40	5.32	2.66	0.98	0.84	0.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.82	5.69	3.56	1.07	0.36	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.91	0.97	1.45	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.58	1.56	0.62	0.31	0.16	0.16	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	9.67	3.58	1.79	0.36	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	1.96	2.61	3.27	0.98	1.31	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.35	1.18	1.65	0.24	1.18	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.42	6.44	1.61	0.50	0.87	0.12	0.25	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.82	2.56	2.31	0.26	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.07	3.58	0.30	1.49	0.30	0.00	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	4.53	2.27	0.00	9.06	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.18	3.84	3.84	1.53	1.53	0.00	3.84	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.75	1.48	2.23	0.00	2.23	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	40.62	1.27	7.19	0.00	4.65	0.42	0.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	27.43	4.22	4.92	0.70	0.00	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.95	1.87	2.80	0.00	3.74	0.00	1.87	0.93	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	28.34	3.61	7.73	1.03	2.06	0.00	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	34.49	3.57	0.00	0.00	2.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	31.89	6.56	4.52	1.36	1.81	0.23	0.68	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	32.86	4.36	6.98	1.16	4.65	0.00	1.16	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	27.01	5.85	8.55	1.80	4.05	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	42.54	4.74	5.01	0.54	4.06	0.41	0.95	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	33.38	5.14	8.73	1.03	3.08	0.51	1.03	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.17	3.53	7.06	0.71	3.18	0.35	1.41	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.99	2.67	2.00	0.00	3.33	0.67	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	47.37	4.58	7.13	2.04	2.04	0.00	1.02	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	22.41	3.74	3.47	3.20	2.40	0.00	2.13	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	26.83	4.35	8.12	1.70	5.48	0.19	1.70	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	40.50	5.52	6.75	0.61	3.07	0.61	1.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	26.09	7.34	5.71	0.00	2.45	0.00	2.45	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	25.41	5.83	8.12	0.83	3.54	0.21	1.46	1.04	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	33.35	6.45	7.01	1.40	3.36	0.00	0.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	4.12	11.33	2.06	3.09	0.00	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.39	4.35	7.55	2.61	2.32	0.29	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	32.58	5.08	5.08	1.79	3.59	0.30	1.49	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	16.60	7.19	7.75	0.00	3.87	0.00	0.00	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	28.63	6.36	6.01	1.06	3.53	0.00	1.41	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	35.40	8.85	7.38	1.11	1.48	0.00	1.11	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	26.48	2.30	2.30	1.15	2.30	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	31.08	5.76	7.29	1.92	0.00	0.77	1.54	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	26.04	5.10	3.96	1.70	1.70	0.57	2.83	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.97	3.28	8.20	1.64	4.92	0.00	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	37.05	6.33	7.68	1.36	2.71	0.45	1.36	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	28.01	6.46	2.87	0.00	0.72	0.72	0.72	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	30.62	4.48	8.22	0.75	2.99	0.00	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	25.27	8.92	5.20	0.00	2.97	0.00	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	27.57	3.45	5.60	0.43	2.58	0.00	1.72	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	31.68	5.99	6.85	0.00	4.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	35.65	7.33	9.00	2.67	4.00	0.33	1.00	1.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	31.37	6.64	10.26	0.00	1.81	0.00	1.81	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	28.44	7.11	10.66	0.71	4.98	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	28.53	5.16	6.19	2.06	3.09	0.00	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	28.45	6.44	2.68	0.00	3.22	0.00	1.61	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	27.61	4.04	6.73	1.35	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	33.71	5.19	6.67	1.48	1.85	0.74	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	41.87	5.81	2.33	1.16	4.65	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	30.67	9.52	4.23	3.17	1.06	0.00	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	32.41	3.20	8.00	0.80	2.80	0.00	2.00	2.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	52.33	4.36	2.18	0.00	5.09	0.00	3.63	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	36.79	1.53	9.20	1.53	6.13	0.77	3.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	37.00	1.48	6.41	1.48	2.96	0.00	1.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	42.34	2.82	10.35	1.88	5.65	0.00	3.76	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	49.78	4.53	7.54	1.01	4.53	0.00	1.01	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	39.65	3.60	7.21	1.35	2.25	0.00	0.00	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	6.88	3.44	0.00	0.00	0.00	3.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	42.75	3.56	6.23	2.67	4.45	0.45	1.34	1.78	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	37.54	6.65	7.82	1.56	3.52	0.00	1.96	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	31.01	2.64	9.90	0.00	4.62	0.66	1.98	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	49.30	2.59	9.86	2.08	3.11	1.04	2.08	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	36.76	5.69	7.44	0.88	0.88	0.00	1.31	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	38.02	7.83	7.27	0.00	4.47	0.00	1.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	34.01	4.86	6.18	3.97	3.53	0.44	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	35.49	5.40	6.94	0.39	5.01	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	37.47	7.09	5.06	0.51	1.52	0.51	2.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	37.49	4.33	7.21	1.92	1.44	0.00	0.48	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	33.00	4.77	5.96	2.78	2.39	0.00	1.59	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	29.77	3.04	11.54	0.00	5.47	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.76	4.15	3.46	3.46	3.46	0.00	0.69	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.80	4.56	6.84	1.90	5.70	0.00	2.28	0.38	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	36.15	3.61	8.78	2.07	5.16	0.00	4.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.30	3.02	3.63	4.23	0.00	0.00	1.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.20	4.44	9.19	1.58	1.90	0.00	0.63	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	39.45	5.33	7.46	0.00	2.67	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	13.79	6.32	6.32	1.72	2.87	0.57	1.72	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	31.88	4.11	6.17	1.54	1.03	0.00	2.57	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.25	4.95	7.78	2.12	1.41	0.00	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	18.73	3.97	5.67	5.67	3.40	0.57	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	37.86	4.16	7.90	0.00	2.91	0.42	0.83	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	32.89	3.13	4.70	0.00	3.13	0.00	0.78	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	9.19	2.51	5.85	5.01	4.59	0.00	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	32.06	6.50	6.04	2.79	3.25	0.00	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	36.13	1.34	4.68	1.34	2.01	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	12.30	1.07	3.21	2.14	1.60	0.00	1.60	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	31.12	5.25	5.66	0.40	2.02	0.40	1.21	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	2.75	8.26	0.92	2.75	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	11.56	2.67	4.45	7.11	4.45	0.00	1.78	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	26.78	6.84	8.55	1.71	6.84	0.00	1.71	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	40.65	4.60	8.44	0.77	2.30	0.00	2.30	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.59	2.19	2.19	1.09	0.55	0.00	0.55	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	29.40	4.01	7.57	0.89	3.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	42.37	6.24	4.42	0.52	1.82	0.26	1.30	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.93	3.98	5.30	1.33	4.64	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	47.81	4.16	10.39	0.00	2.08	0.00	2.08	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	15.73	11.85	2.28	0.68	0.00	0.46	0.23	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	10.64	10.28	3.67	0.00	0.55	0.73	0.37	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	18.74	13.37	1.57	0.79	0.66	0.39	0.26	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.84	7.97	2.12	0.00	0.00	0.53	0.00	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	9.51	7.92	1.43	0.16	0.79	0.32	0.48	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	7.23	7.78	1.25	0.14	0.28	0.14	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	19.53	20.43	5.18	1.00	0.70	1.00	0.30	0.20	0.30
Mammary Epithelial Cell, donor2	11350-117G9	9.56	11.00	2.90	0.87	0.58	0.29	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	2.99	3.49	1.25	0.75	0.25	0.25	0.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	35.25	16.95	6.10	2.03	2.71	0.68	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	71.16	10.81	11.79	2.81	0.54	0.32	0.22	0.11	0.97
Mast cell, donor2	11565-120D8	79.64	22.29	15.16	2.67	1.19	0.30	0.30	0.00	2.08
Mast cell, donor3	11566-120D9	60.11	21.84	14.63	3.38	1.35	0.45	1.58	0.00	1.58
Mast cell, donor4	11567-120E1	91.30	29.78	22.34	4.25	1.95	1.06	0.35	0.53	3.19
Mast cell, expanded and stimulated, donor5	11940-126A5	48.79	12.20	5.99	2.44	0.89	0.33	1.00	0.67	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	53.12	16.34	6.42	0.00	0.58	0.58	0.00	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	32.58	9.98	5.39	1.84	0.23	0.00	0.34	0.11	0.80
Mast cell, expanded, donor8	11941-126A6	59.25	11.72	10.04	1.67	0.67	1.00	0.33	0.33	1.00
Melanocyte - dark, donor1	11502-119F8	24.18	7.96	3.78	0.99	1.19	0.10	0.10	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	8.65	6.58	2.42	2.08	0.00	0.69	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	19.56	12.89	4.78	1.67	0.94	0.29	0.51	0.00	0.07
Melanocyte - light, donor1	11274-116H5	7.05	6.11	1.65	0.24	0.00	0.47	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	5.46	3.41	2.73	0.00	0.68	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	4.34	2.60	0.00	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	8.33	13.22	3.54	1.15	0.42	0.21	0.42	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	11.83	7.26	5.92	0.54	0.27	0.27	0.54	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	13.93	9.11	4.29	1.34	0.80	0.00	0.27	0.00	0.54
Meningeal Cells, donor1	11493-119E8	4.71	6.95	3.60	1.74	0.25	0.12	0.25	0.12	0.00
Meningeal Cells, donor2	11573-120E7	3.96	5.72	0.88	2.64	0.00	0.44	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	13.45	17.20	4.32	0.82	1.06	0.73	0.41	0.41	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	14.83	14.54	5.42	0.57	0.00	0.29	0.00	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.47	6.94	6.74	0.81	0.70	0.20	0.20	0.20	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	3.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	5.23	2.62	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	9.33	9.33	2.15	0.00	0.00	1.44	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.49	8.68	3.39	0.85	1.06	0.00	0.21	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	8.54	6.53	3.02	0.00	0.50	0.00	1.01	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.93	5.93	1.10	0.00	0.44	0.22	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	6.58	5.84	2.19	0.73	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	3.48	9.82	2.25	0.20	0.00	0.00	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	2.77	4.99	2.08	0.97	0.14	0.55	0.14	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.58	3.72	1.12	0.00	0.37	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	13.82	12.10	3.68	0.53	0.26	0.66	0.66	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.04	5.93	1.19	0.59	0.00	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	4.48	4.48	1.28	0.00	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.03	13.47	1.77	1.77	0.00	0.00	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	11.57	11.57	3.13	0.94	0.63	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.81	8.71	4.35	2.18	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	5.83	7.42	1.86	0.53	1.06	0.27	0.80	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	8.01	8.01	2.00	0.00	0.00	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	9.18	7.95	2.17	0.43	0.22	0.14	0.43	0.58	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	6.75	2.70	4.05	1.35	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	8.13	7.14	7.63	1.97	0.74	0.49	0.25	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.89	6.77	6.18	0.59	0.59	0.59	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	10.37	3.46	3.46	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.40	6.20	4.96	2.17	0.00	0.00	0.62	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.30	7.68	5.60	0.62	0.21	0.21	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	4.63	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	11.01	8.26	5.76	1.50	0.25	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	10.24	10.71	4.19	1.86	0.47	0.00	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.91	4.67	4.27	2.64	0.81	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	10.69	6.73	3.17	0.40	1.58	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	0.88	5.31	0.00	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.08	9.88	5.32	0.76	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	6.58	0.00	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	4.67	6.15	3.18	1.49	0.21	0.21	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	5.52	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.45	4.47	3.87	1.79	0.00	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6.77	3.26	3.76	2.26	1.51	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.84	3.57	3.09	0.71	0.48	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.19	3.32	3.87	0.00	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	10.36	2.76	1.61	0.69	0.92	0.00	0.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.41	4.00	2.52	0.21	0.21	0.21	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.17	6.11	2.45	0.41	0.20	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.87	5.79	1.72	0.21	0.21	0.21	0.43	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.00	5.33	2.00	0.89	0.67	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.95	5.26	1.97	0.88	0.44	0.00	0.66	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.06	4.06	1.52	0.51	0.51	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	4.97	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.70	3.26	1.90	1.09	0.27	0.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.41	3.53	3.82	0.00	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	4.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	7.21	2.88	1.44	0.48	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.80	8.40	2.00	0.00	0.40	0.40	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	6.86	0.00	2.74	0.00	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.51	4.00	4.00	1.00	0.00	0.50	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.26	7.88	1.75	1.31	0.44	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	4.41	0.00	3.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	4.48	0.64	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.21	6.69	2.48	0.25	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.09	7.65	0.70	0.70	0.00	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	7.52	5.47	0.00	1.37	0.34	0.34	1.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	2.63	5.69	0.00	1.31	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.04	6.75	1.78	0.36	0.00	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.37	8.70	1.12	0.28	0.56	0.28	0.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.91	6.23	2.08	0.00	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	6.41	1.17	0.58	1.17	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.65	9.05	2.71	1.21	0.30	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.59	5.43	2.92	0.42	0.42	0.42	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	7.39	0.92	0.00	0.92	1.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	4.55	5.69	0.57	0.57	1.14	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	3.87	7.60	1.11	0.14	0.14	0.14	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.70	6.48	1.04	1.04	0.52	0.26	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.43	6.43	1.72	0.43	0.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.72	5.72	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.74	8.27	1.87	0.27	0.27	0.27	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	8.08	9.58	2.10	1.50	0.90	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.37	8.76	1.55	0.00	0.57	0.42	0.28	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	6.05	7.33	1.27	0.64	0.64	1.59	0.32	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	5.31	8.40	1.77	1.33	0.00	0.44	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	3.41	6.07	1.52	0.00	1.52	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.69	9.66	1.42	1.70	1.14	0.85	0.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.88	7.87	3.44	0.74	1.23	0.49	0.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.91	8.47	0.65	0.00	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.88	11.17	2.06	0.59	0.29	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	6.34	9.23	2.59	0.00	0.58	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	13.19	12.36	1.65	0.00	0.82	0.41	0.82	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.34	7.15	0.60	0.89	0.89	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	3.77	7.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	8.91	7.13	0.00	1.78	0.00	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	15.11	5.59	2.30	1.31	0.66	0.66	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	3.16	5.26	1.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.63	6.52	1.78	1.38	0.99	0.20	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	5.59	2.79	1.86	0.00	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.52	4.88	2.25	0.75	0.38	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.72	7.72	1.60	0.53	0.27	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.14	5.32	1.13	0.11	0.34	0.00	0.00	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.00	2.21	2.95	0.00	0.00	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.19	2.56	2.93	0.73	0.00	0.00	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	1.56	4.67	3.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	18.71	4.81	0.00	0.00	0.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	3.03	1.01	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.49	4.64	1.69	1.26	0.42	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	122.57	1.36	5.45	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	43.87	4.45	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	28.34	2.43	1.62	0.00	0.81	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	51.35	4.53	12.08	3.02	0.00	0.00	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	1496.06	11.42	74.23	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	414.33	19.57	35.89	3.26	6.52	3.26	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	213.86	9.50	14.26	0.00	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	464.32	0.00	87.84	25.10	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	13.57	9.05	3.66	0.86	1.72	0.22	0.86	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7.32	13.59	3.66	1.05	0.00	0.00	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	5.34	3.34	0.00	0.00	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.11	7.93	3.34	0.42	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	18.44	22.25	4.18	0.76	1.33	0.38	0.38	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	7.98	3.19	0.00	1.60	0.00	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	2.72	0.68	0.00	0.00	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	22.05	7.35	1.84	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.97	2.51	1.26	0.00	0.00	0.00	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.09	4.65	1.86	0.46	0.23	0.23	0.23	0.93	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.27	5.40	1.62	0.27	0.27	0.27	0.00	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.09	7.15	6.52	0.84	1.05	0.00	0.63	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	33.40	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.93	3.47	1.99	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.41	8.93	3.25	0.27	0.54	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.97	4.76	0.91	0.23	0.00	0.23	0.23	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.53	3.27	1.63	0.33	0.16	0.33	0.00	0.65	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.75	5.29	4.37	1.09	0.00	0.55	0.73	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	6.90	3.18	0.53	0.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.61	3.00	3.00	0.00	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	13.78	6.24	4.27	1.31	0.33	0.00	0.98	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.85	4.07	2.44	0.33	0.00	0.00	0.00	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	15.35	7.06	5.29	1.41	0.18	0.35	0.35	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	20.39	4.22	2.11	0.00	0.00	0.00	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.45	3.68	1.84	1.38	0.46	0.00	0.46	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.32	5.14	1.61	0.32	0.64	0.00	0.32	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.49	11.38	5.17	1.38	1.03	0.69	0.69	1.38	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	35.40	12.64	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.26	3.56	5.35	1.34	0.89	0.00	0.45	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	14.82	5.08	1.69	0.00	0.42	0.42	0.00	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.84	5.22	3.32	0.00	0.00	0.47	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.46	0.86	1.29	0.00	0.86	0.00	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	36.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.33	5.00	2.00	0.33	0.67	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.92	4.96	2.71	0.90	0.00	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	10.32	5.95	1.19	0.79	0.00	0.00	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	3.71	2.79	0.00	0.00	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	25.35	6.81	8.70	0.38	1.14	0.00	0.38	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.12	2.93	2.28	0.00	0.00	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.38	5.23	1.74	0.00	0.00	0.44	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	13.12	6.33	2.71	1.81	0.45	0.45	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	19.40	2.65	0.00	0.00	0.00	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	22.60	1.99	1.99	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	19.35	2.98	4.96	0.00	0.00	0.50	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.63	4.98	3.06	0.00	0.77	0.38	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	23.59	9.68	4.84	0.00	0.00	0.30	0.91	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	8.62	6.19	3.09	1.77	0.66	0.22	0.88	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.13	4.07	0.68	0.00	0.68	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11	15.33	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	22.56	5.49	4.27	0.61	0.00	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.48	5.35	1.89	0.00	0.00	0.31	0.31	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.95	4.54	3.33	0.30	0.30	0.00	0.30	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.82	5.54	1.58	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	20.41	13.60	7.94	0.00	1.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	5.06	25.29	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.32	8.32	1.49	0.37	0.62	0.12	0.62	0.37	0.00
Myoblast, donor2	11322-117D8	8.44	10.93	4.60	1.53	0.96	0.58	0.38	0.58	0.00
Myoblast, donor3	11398-118D3	16.14	11.44	3.87	0.50	0.67	0.34	0.34	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	31.52	11.53	3.79	1.75	1.17	0.15	0.73	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	50.74	6.46	11.99	2.77	5.54	0.31	2.15	0.92	0.62
Natural Killer Cells, donor2	11311-117C6	62.12	5.73	17.49	5.13	1.51	0.60	3.02	0.90	0.60
Natural Killer Cells, donor3	11387-118C1	78.59	11.78	5.71	1.47	1.84	0.37	2.02	1.29	0.18
Neural stem cells, donor1	11275-116H6	22.50	22.14	11.25	0.73	3.27	0.73	0.73	0.73	0.00
Neural stem cells, donor2	11352-117H2	30.81	30.81	13.48	0.00	0.00	1.93	1.93	0.00	0.00
Neurons, donor1	11494-119E9	23.90	17.07	10.24	2.28	2.28	2.28	1.14	0.00	0.00
Neurons, donor2	11574-120E8	22.46	16.95	9.03	1.98	0.88	1.10	0.44	0.22	0.00
Neurons, donor3	11655-122E8	37.82	15.62	14.80	1.64	0.82	0.82	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	27.84	19.49	5.57	0.00	0.93	0.93	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	20.29	5.80	5.80	2.90	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	42.15	37.87	7.33	0.00	0.00	0.61	4.28	1.83	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	15.79	15.55	3.44	0.71	0.12	0.95	0.12	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	11.07	12.37	3.91	0.65	0.00	1.30	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	4.21	6.42	2.81	3.81	0.00	0.40	0.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	11.01	7.16	3.03	1.38	0.55	0.28	0.83	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	14.33	8.11	3.47	2.17	0.14	0.29	0.29	0.58	0.00
Olfactory epithelial cells, donor3	11935-125I9	11.12	7.15	3.86	1.02	0.57	0.45	0.45	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	6.92	9.74	2.53	0.88	0.19	0.19	0.19	0.39	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	9.03	10.83	3.01	1.20	0.60	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	5.96	2.98	2.55	0.00	0.00	0.00	0.21	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	4.57	4.57	1.14	0.00	0.00	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.93	4.34	1.86	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	3.52	4.30	3.32	0.59	0.00	0.20	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	9.13	15.45	4.21	0.70	1.40	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	9.95	7.64	1.96	0.00	0.53	0.00	0.71	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	16.51	15.42	2.27	0.84	0.76	0.51	0.51	0.34	0.17
Pericytes, donor1	11491-119E6	2.11	2.34	0.89	0.56	0.45	0.11	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	3.17	3.62	1.58	1.36	0.23	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	3.46	5.70	2.03	0.61	0.20	0.00	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	10.06	14.13	3.39	1.81	0.11	0.45	0.79	0.00	0.00
Perineurial Cells, donor2	11579-120F4	11.50	16.01	2.39	0.74	0.46	0.37	0.18	0.55	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	32.19	9.24	5.10	0.96	3.82	0.00	1.91	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	25.71	9.06	5.39	1.47	0.98	0.00	0.49	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	25.88	7.89	2.20	0.39	2.33	0.13	2.07	0.26	0.00
Placental Epithelial Cells, donor1	11278-116H9	14.11	1.91	4.07	0.96	0.00	0.00	0.00	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	2.22	4.44	1.11	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.71	2.94	1.57	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.23	3.48	1.58	0.00	0.32	0.32	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	9.00	6.57	3.19	0.19	0.56	0.00	0.94	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.18	11.36	2.74	1.44	1.04	0.52	0.52	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	9.01	5.18	4.05	0.68	1.35	0.23	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	14.71	8.74	5.43	0.64	1.17	0.32	0.53	0.32	0.21
Preadipocyte - omental, donor2	11329-117E6	12.66	10.04	0.87	0.87	0.44	0.44	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	18.05	15.47	1.29	0.57	2.44	0.29	0.29	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	2.95	1.97	0.00	0.00	0.00	0.00	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	7.06	7.06	3.69	0.31	0.00	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	8.32	17.00	7.44	1.24	0.53	0.53	0.18	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	13.62	10.05	2.38	0.68	0.34	0.17	0.85	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	9.13	17.05	4.28	1.30	1.12	0.75	0.65	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	12.89	14.27	3.68	0.46	1.38	0.46	0.00	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	2.72	7.94	3.66	1.78	0.84	0.21	0.21	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	25.19	8.00	2.72	1.06	1.21	0.00	0.30	0.00	0.30
Prostate Epithelial Cells, donor2	11331-117E8	3.25	9.21	3.39	0.54	0.41	0.81	0.27	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	14.70	16.17	1.65	0.43	1.04	0.49	0.49	0.18	0.24
Prostate Stromal Cells, donor1	11254-116F3	10.93	12.87	2.39	0.34	1.14	0.80	0.11	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	12.91	13.99	7.71	1.61	0.72	0.36	0.36	0.36	0.18
Prostate Stromal Cells, donor3	11405-118E1	8.03	13.66	1.56	0.21	0.42	0.21	0.21	0.00	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	1.82	3.65	1.46	0.00	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	4.51	12.55	2.22	0.69	0.35	0.21	0.28	0.21	0.00
Renal Epithelial Cells, donor1	11517-119H5	2.54	6.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	1.42	4.27	1.42	0.00	0.00	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	5.29	17.04	2.96	0.85	0.53	0.21	0.11	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	0.00	3.40	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	2.16	2.16	1.21	1.35	0.27	0.13	0.13	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	12.65	11.10	4.44	1.33	0.67	0.00	0.22	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	2.64	5.94	1.54	0.22	0.00	0.00	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	2.51	3.76	0.63	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	0.83	3.33	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	3.76	7.25	1.88	0.54	0.27	0.54	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.95	6.33	1.27	0.00	0.42	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	3.47	7.14	1.74	0.58	0.19	0.19	0.19	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.48	10.89	4.15	0.52	0.52	0.00	0.78	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	5.97	3.98	1.14	0.00	0.28	0.57	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.31	7.53	3.76	0.50	0.00	0.75	0.50	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	23.65	16.30	7.48	0.80	2.94	0.53	0.27	0.13	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	25.02	10.72	3.57	0.00	0.00	0.00	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.31	7.15	2.20	0.55	1.10	0.00	2.20	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	17.98	11.60	2.90	0.00	2.90	0.00	2.32	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	10.27	12.35	3.77	3.77	2.34	0.39	1.56	1.30	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	13.60	14.40	7.05	1.89	1.59	0.20	1.39	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	18.85	15.06	4.68	1.12	1.56	0.78	0.78	1.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	4.34	9.68	4.71	5.95	1.61	0.50	1.12	0.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	13.64	13.29	6.53	1.05	0.70	1.05	0.70	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	13.17	16.64	5.55	1.16	1.39	1.16	0.69	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	5.07	5.61	5.20	3.42	1.78	0.27	1.37	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	14.82	11.65	6.66	0.76	1.21	0.30	1.21	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	14.87	15.95	4.66	1.43	1.43	0.90	0.36	1.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	5.45	6.46	4.30	2.73	1.15	0.14	1.15	1.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	11.70	14.92	6.44	1.61	1.07	0.75	1.07	0.54	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	15.05	15.93	5.53	1.55	1.55	0.22	1.55	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.54	5.35	3.06	1.53	2.87	0.38	0.96	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	12.67	16.21	5.68	0.93	1.49	0.28	0.93	1.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	18.60	18.04	2.63	0.19	2.07	0.38	1.88	1.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	3.45	6.37	3.72	3.72	2.26	0.13	1.06	1.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	12.07	12.85	3.89	0.97	2.24	0.58	1.85	0.97	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	17.57	17.19	2.48	1.34	3.06	0.95	1.34	1.72	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	3.20	6.30	2.35	3.10	2.14	0.32	1.07	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	13.45	9.53	3.64	0.56	1.96	0.28	1.12	1.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	12.30	10.42	8.20	0.51	1.03	0.34	1.03	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	6.38	5.11	2.92	2.73	1.46	0.36	0.55	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	13.24	10.42	3.92	0.86	0.98	0.12	1.23	1.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	14.51	15.85	3.76	0.54	2.15	0.40	1.21	1.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	6.13	8.26	3.07	3.54	2.83	0.47	1.18	2.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	14.29	15.08	5.75	0.60	3.17	0.20	0.99	1.39	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	17.07	19.18	6.08	2.34	1.87	0.47	0.47	1.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	8.09	7.46	4.35	3.73	1.45	0.21	1.04	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	18.58	10.62	4.65	0.22	2.21	0.66	0.88	1.11	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	17.96	19.01	9.40	1.46	2.72	0.42	0.84	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	8.34	9.96	5.11	5.11	2.42	0.67	1.08	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.92	13.79	5.45	1.53	2.90	0.34	1.19	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	17.35	19.86	7.71	0.96	1.16	0.39	0.96	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	6.19	6.88	3.44	4.81	1.55	0.34	1.89	0.69	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	20.71	19.75	4.39	2.47	0.96	0.14	1.23	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	22.82	15.60	6.57	0.82	2.13	0.82	1.48	1.48	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	5.45	4.26	2.90	2.73	1.36	0.17	0.68	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.02	13.02	4.44	1.33	0.89	0.30	0.89	1.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	16.26	14.39	4.53	0.53	2.40	0.27	0.53	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	4.98	3.73	3.04	3.87	1.52	0.28	0.83	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	14.05	17.14	7.14	0.71	1.43	0.00	0.95	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	19.95	15.12	3.83	1.21	2.02	0.81	1.41	1.01	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	5.56	6.50	4.90	3.67	1.51	0.66	1.79	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	24.46	15.02	4.89	1.05	0.35	0.35	0.70	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	23.27	11.18	5.44	1.51	1.21	0.00	1.21	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	5.14	5.26	3.92	2.94	2.20	0.24	1.35	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	43.37	16.88	6.84	1.46	3.64	0.58	2.47	1.89	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	29.81	12.17	5.48	2.43	1.22	0.00	1.22	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	3.01	3.32	1.21	1.81	2.11	0.00	0.90	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	22.85	11.31	9.73	0.68	0.68	0.00	0.90	0.23	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	26.66	13.18	7.49	0.60	1.20	0.90	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	10.98	5.20	3.42	2.36	2.24	0.12	1.06	0.94	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	25.83	10.67	8.75	1.71	1.49	0.43	0.85	0.43	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	17.43	12.62	5.41	1.20	1.20	0.00	0.00	0.60	1.80
Schwann Cells, donor1	11498-119F4	1.50	2.63	2.26	1.32	0.19	0.75	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	13.61	3.40	10.21	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	9.42	9.86	4.60	1.31	0.44	0.22	0.00	0.44	0.00
Sebocyte, donor1	11220-116B5	3.29	13.15	1.64	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	2.30	4.60	1.84	0.46	0.46	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	2.27	5.77	0.21	0.00	0.00	0.21	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	16.57	14.91	0.00	1.66	1.66	0.00	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	2.82	11.30	2.82	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	14.78	9.33	3.43	1.06	0.35	0.62	0.44	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	8.67	0.72	0.72	0.00	0.72	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	8.36	5.85	0.00	1.67	0.00	0.84	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	3.93	7.85	4.24	2.98	0.16	0.16	0.00	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	3.42	4.76	2.97	2.38	0.30	0.45	0.15	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	3.85	8.00	3.54	2.00	0.31	0.31	0.15	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	8.06	18.77	2.14	0.88	0.38	0.50	0.13	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	7.56	9.70	4.42	1.43	0.14	0.14	0.29	0.29	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	9.03	20.34	3.67	0.40	0.20	0.89	0.30	0.10	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	16.68	11.96	4.21	1.01	0.34	0.34	0.59	0.25	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.79	7.24	3.62	1.45	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.16	2.34	1.79	1.65	0.00	0.00	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	18.80	2.69	2.69	0.00	0.00	0.00	0.00	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.19	7.06	0.86	0.14	0.29	0.14	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	4.91	9.81	4.09	0.00	0.00	0.00	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.45	4.93	1.04	0.26	0.13	0.26	0.00	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	12.37	12.23	1.53	0.42	0.28	0.42	0.00	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	10.69	6.47	3.24	0.84	0.42	0.56	0.28	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	15.01	16.49	2.54	1.90	0.42	0.85	0.21	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	22.64	13.42	1.95	1.27	0.30	0.15	0.07	0.00	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1.85	2.47	1.85	1.23	0.31	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2.67	6.67	2.89	0.89	0.22	0.67	0.89	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	7.05	7.64	2.35	0.00	0.00	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	4.86	2.87	1.10	0.66	0.22	0.22	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	1.97	6.30	0.79	0.39	0.39	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	12.36	5.41	3.86	0.77	0.00	0.00	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	14.01	11.01	3.00	0.00	0.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	4.92	8.78	2.53	0.27	0.40	0.27	0.00	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	9.75	11.97	6.43	1.33	0.66	0.00	0.66	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	5.12	6.15	2.94	1.66	0.64	0.26	0.38	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	6.51	9.12	2.93	1.30	0.33	0.98	0.33	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	12.99	14.77	4.43	1.18	0.00	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	6.26	8.54	0.85	0.28	0.28	0.43	0.00	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.77	2.77	1.14	0.16	0.16	0.16	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	9.13	6.70	1.83	0.91	0.00	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	7.58	8.84	2.02	0.25	0.51	0.00	0.25	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	134.66	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1.43	2.38	0.48	0.48	0.48	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	6.34	9.29	2.51	0.15	0.00	0.15	0.15	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	5.60	8.61	4.09	0.65	0.22	0.43	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	9.45	13.33	1.36	0.10	0.52	0.31	0.42	0.00	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	3.09	3.87	1.39	0.46	0.15	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	2.16	6.47	2.16	0.00	0.00	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	0.60	3.59	1.49	1.20	0.00	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2.73	3.76	0.68	0.00	0.34	0.00	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	9.82	10.92	3.22	0.63	0.31	0.16	0.24	0.63	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	8.76	16.81	4.23	0.60	1.01	0.60	0.30	0.30	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	10.47	13.65	5.69	1.37	0.00	0.68	0.23	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	1.81	0.60	1.21	0.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	16.16	16.16	3.71	2.65	0.53	0.53	0.53	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	5.86	8.66	2.80	3.33	0.53	0.67	0.27	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	7.26	11.90	4.51	1.13	0.38	0.25	0.25	0.25	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.83	3.30	2.03	0.25	0.51	0.51	1.27	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	7.09	14.02	3.77	0.90	0.90	0.75	0.15	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	1.50	7.50	2.25	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	9.05	6.46	1.29	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.05	11.63	2.33	0.47	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	3.53	6.56	3.03	0.00	1.01	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	3.13	3.76	1.25	2.19	0.31	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.18	1.77	1.18	0.29	0.00	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	11.50	24.33	4.17	2.58	0.58	0.58	0.17	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.41	9.34	2.80	0.47	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.17	3.74	1.15	0.29	0.00	0.00	0.00	0.43	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	4.08	3.06	1.27	0.76	0.25	0.00	0.00	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2.07	2.82	2.44	1.69	0.19	0.19	0.00	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	9.92	15.79	2.38	0.98	0.14	0.14	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.86	7.21	1.68	1.17	0.25	0.50	0.42	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	2.38	0.95	0.00	0.95	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	3.91	4.40	0.98	0.00	0.24	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	6.63	7.29	3.09	2.65	0.88	0.66	0.44	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	6.73	10.53	1.17	0.88	0.29	0.88	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.85	7.19	0.78	0.00	0.19	0.78	0.58	0.39	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	6.35	7.40	0.79	0.00	0.53	0.00	0.00	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.67	4.46	1.12	0.74	0.74	0.37	0.37	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.62	11.14	1.44	0.36	0.72	0.00	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.54	8.23	0.28	0.28	0.00	0.00	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.54	7.09	1.58	0.39	0.79	0.00	0.79	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	7.11	8.38	2.29	1.02	0.25	0.25	0.51	0.00	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	17.17	10.78	0.80	0.40	0.00	0.80	0.00	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	13.38	3.76	2.51	0.00	0.42	0.42	0.42	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	21.54	9.17	4.13	0.46	0.46	0.92	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	18.68	9.93	4.71	0.67	1.51	0.34	1.35	0.34	0.00
Synoviocyte, donor2	11368-117I9	13.75	10.39	1.34	0.34	0.34	0.34	0.00	0.17	0.00
Synoviocyte, donor3	11440-118H9	1.79	4.92	1.12	1.12	0.22	0.22	0.22	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	5.36	5.72	3.22	0.00	0.00	0.00	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.56	7.41	2.08	0.69	0.00	0.00	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	3.23	5.66	1.94	0.29	0.29	0.14	0.07	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	5.41	1.16	0.39	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	3.44	2.86	0.57	1.15	0.00	0.00	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	24.97	15.38	7.87	0.98	2.46	0.49	0.25	0.00	0.37
Urethra, donor2	10319-105A4	7.19	8.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	3.19	2.92	0.80	0.00	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.20	4.41	1.20	0.00	0.40	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	0.92	1.60	0.69	0.00	0.00	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	6.69	9.36	1.56	0.67	0.22	0.45	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	8.01	8.01	9.79	2.67	0.00	0.89	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	11.44	12.87	5.72	5.72	1.43	0.00	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.06	19.85	16.43	2.05	0.00	0.68	0.00	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	22.38	20.66	5.85	4.13	2.07	0.69	0.34	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	23.82	24.98	8.13	1.74	0.00	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	12.49	11.45	4.16	6.25	1.04	0.00	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	12.85	10.10	9.18	2.75	0.00	0.00	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	14.61	16.43	10.95	1.83	0.00	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	18.26	16.65	6.17	0.37	1.48	1.11	0.25	0.25	0.00
Wilms' tumor cell line:HFWT	10597-108E3	14.08	14.96	5.28	0.88	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	7.54	16.48	5.03	1.12	0.56	0.56	0.84	0.84	0.00
achilles tendon, donor2	10292-104G4	39.26	4.13	6.20	0.00	0.00	0.00	4.13	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	28.05	21.42	7.14	0.76	0.76	1.78	0.51	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	41.09	20.20	6.97	2.55	1.86	1.16	0.46	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	32.88	24.81	6.53	1.07	2.26	0.59	0.95	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	26.67	25.58	2.99	1.09	1.09	1.63	0.27	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	16.02	14.90	7.59	1.12	0.56	0.00	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	19.24	11.63	3.38	0.63	1.27	0.21	0.21	0.63	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	21.23	13.07	8.71	0.82	5.44	0.00	1.36	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	15.42	4.41	2.64	0.00	1.32	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	18.78	5.31	6.94	0.41	1.23	0.41	0.00	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	45.82	9.32	5.44	0.78	0.78	0.78	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	8.65	8.28	3.31	0.18	0.92	0.18	0.00	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	3.90	15.60	0.00	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	21.61	11.85	7.90	0.70	1.86	0.23	0.70	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	18.64	12.17	10.87	1.04	0.52	0.78	1.55	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	16.37	17.53	6.14	0.88	2.63	0.58	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	21.84	10.22	7.90	1.39	1.86	0.00	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	40.71	10.28	6.58	0.82	0.82	0.41	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	24.56	8.59	5.22	0.31	0.31	0.31	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	23.47	17.07	2.13	0.85	2.99	0.85	0.43	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	20.93	12.74	3.34	0.00	2.43	0.30	0.30	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	22.39	17.33	2.89	0.48	2.65	0.72	0.48	1.44	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	13.81	6.24	5.79	0.89	1.34	0.22	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	28.35	15.68	18.01	2.67	2.67	1.33	1.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	26.01	24.16	1.86	1.86	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	19.96	24.48	9.42	1.51	2.26	0.75	0.38	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	30.09	6.54	9.16	1.31	2.18	0.44	0.87	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	54.36	20.62	5.62	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	26.61	11.77	0.94	0.47	1.88	0.00	0.24	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	21.56	15.67	7.45	1.55	2.64	0.78	0.62	0.00	0.62
adipose, donor1	10184-103D4	35.18	44.57	27.56	5.28	0.00	0.59	0.59	0.00	4.69
adipose, donor2	10185-103D5	39.74	32.44	19.87	1.22	0.41	2.03	0.00	0.00	1.22
adipose, donor3	10186-103D6	82.50	28.32	16.07	3.00	0.54	1.63	0.00	0.27	4.36
adipose, donor4	10187-103D7	156.88	31.20	17.34	2.60	0.00	0.87	0.00	0.87	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	31.72	56.66	6.31	1.26	0.32	3.31	0.00	0.32	0.16
adrenal gland, adult, pool1	10081-102A9	14.55	7.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	9.34	10.01	1.60	0.53	0.00	0.40	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	12.51	16.08	6.43	0.71	0.36	0.00	0.71	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	20.63	18.78	4.41	2.09	2.55	0.70	0.46	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	19.61	7.10	5.41	0.68	1.35	0.68	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	6.19	8.84	9.13	4.71	1.18	0.59	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	27.27	18.97	7.11	1.19	1.19	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	20.89	27.98	8.11	3.65	1.82	1.22	1.01	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	20.98	19.69	2.58	0.65	0.00	1.29	1.29	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	29.03	6.37	7.00	0.89	0.25	0.25	0.25	0.25	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	33.98	11.03	3.75	1.10	1.32	0.22	0.44	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	61.46	34.41	14.03	2.00	0.33	2.00	1.00	0.33	0.67
aorta, adult, pool1	10052-101G7	27.07	23.54	3.14	1.57	1.37	0.39	0.00	0.00	0.00
appendix, adult	10189-103D9	25.62	12.81	12.03	3.10	2.33	0.39	1.55	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	17.54	16.85	3.10	0.69	0.69	1.03	0.00	0.00	0.00
artery, adult	10190-103E1	16.30	6.79	6.79	0.00	0.00	1.36	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	28.97	23.90	8.55	1.59	2.46	1.16	0.87	0.72	0.00
b cell line:RPMI1788	10427-106D4	13.83	16.95	4.16	0.89	0.30	0.59	0.15	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	12.21	12.21	4.72	0.00	0.28	0.83	0.83	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.90	17.27	3.47	0.89	2.08	0.99	0.30	0.00	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	24.77	6.86	6.70	0.67	6.03	0.00	1.17	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	31.32	8.95	13.98	6.71	1.12	0.00	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	15.10	15.64	4.56	0.43	0.43	0.43	0.11	0.00	0.11
blood, adult, pool1	10053-101G8	31.00	17.72	2.21	4.43	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.13	10.28	8.56	0.86	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	21.59	13.50	6.75	3.37	2.02	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	24.60	9.23	3.08	3.08	0.00	2.05	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	22.05	36.64	11.80	2.34	0.89	2.23	0.78	0.45	0.33
brain, fetal, pool1	10085-102B4	13.36	26.71	8.01	0.00	0.00	8.01	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	21.47	5.95	3.63	1.32	3.63	0.66	1.65	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	48.93	23.09	8.24	1.37	5.99	0.50	2.62	1.50	0.12
breast, adult, donor1	10080-102A8	12.00	6.94	1.89	0.00	1.26	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	33.92	20.20	3.81	0.76	1.02	1.40	0.00	0.38	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	16.70	15.46	8.66	0.62	0.93	0.93	0.31	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.76	15.65	5.53	1.84	1.61	0.23	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	7.02	5.81	4.84	0.00	0.24	0.48	0.73	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	9.87	20.69	9.40	4.23	0.47	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	33.03	13.89	3.83	0.88	1.53	0.44	0.44	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	9.19	10.77	3.17	1.58	0.32	0.95	0.32	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	37.26	10.91	8.52	1.33	0.27	0.00	1.60	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	28.78	19.57	3.45	2.30	2.30	1.15	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	21.08	33.13	7.70	3.18	3.35	0.67	1.17	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	24.45	25.22	3.82	0.76	1.53	2.29	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	21.61	14.28	6.59	1.10	1.83	1.46	0.73	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	17.48	61.18	23.31	0.00	0.00	11.65	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	33.95	90.74	20.92	8.75	2.99	4.91	1.71	0.85	0.85
cerebellum, adult, pool1	10083-102B2	19.32	40.70	7.24	2.76	1.72	1.38	0.34	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	29.89	18.27	4.98	0.00	0.00	0.83	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	12.61	20.68	11.60	1.26	0.76	1.51	0.76	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	30.70	5.12	5.85	0.00	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	6.90	15.53	2.88	1.15	2.01	0.72	0.58	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	24.36	9.78	6.96	1.16	0.83	0.33	0.17	0.17	0.17
cervix, adult, pool1	10013-101C4	21.21	23.20	6.09	1.05	0.84	1.15	0.21	0.21	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	16.44	4.46	5.71	0.42	1.11	0.00	0.00	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	2.61	3.92	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	12.80	16.16	2.36	0.37	1.12	0.87	0.62	0.12	0.12
choriocarcinoma cell line:SCH	10785-110H2	26.98	19.47	3.57	2.09	2.09	1.11	0.74	0.25	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	8.54	11.15	2.61	1.19	0.71	0.24	0.47	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	21.08	13.11	5.13	1.14	1.99	0.28	0.00	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	12.33	15.01	3.58	0.99	0.80	0.20	0.20	0.30	0.50
chorionic membrane cells, donor3	12240-129G8	10.99	7.14	7.14	5.49	1.10	0.55	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	21.21	3.03	2.02	1.01	2.02	0.00	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	26.32	11.14	3.84	0.77	1.54	0.00	0.38	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	30.20	21.54	4.86	1.48	0.42	0.21	0.21	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	10.02	14.38	1.80	1.28	0.51	0.00	1.28	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	9.92	15.48	3.87	1.21	3.39	0.73	0.00	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.59	13.23	3.66	1.63	3.05	0.41	1.22	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	17.08	14.43	7.07	1.47	1.77	0.88	0.88	0.88	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	60.73	46.13	11.47	1.04	2.09	0.52	1.82	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	6.40	10.06	2.29	0.00	0.69	0.46	0.00	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	13.01	6.94	1.74	0.87	0.17	0.00	0.00	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	23.80	15.92	6.22	1.65	3.48	0.73	0.92	0.55	0.00
colon carcinoma cell line:COLO-320	10420-106C6	16.72	12.54	3.42	0.00	1.52	0.76	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	10.71	7.14	3.57	1.19	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	21.62	13.75	7.17	0.71	1.65	0.47	0.24	0.24	0.71
colon, fetal, donor1	10070-101I7	15.45	8.65	3.09	0.62	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	87.09	18.33	4.58	0.00	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	48.44	16.15	13.60	1.27	2.97	0.42	0.42	1.27	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	19.32	8.90	4.83	1.36	1.66	1.06	0.60	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	16.64	11.56	6.06	1.55	1.27	0.14	0.28	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	35.93	25.54	12.71	1.55	2.54	1.44	1.33	0.22	0.00
cruciate ligament, donor2	10295-104G7	27.56	7.29	7.29	0.00	0.00	0.00	0.81	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	16.85	4.01	2.41	0.80	0.00	0.00	0.00	0.00	0.80
diencephalon, adult	10193-103E4	24.24	27.36	8.16	2.64	1.68	1.20	0.00	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	25.03	12.40	7.12	0.46	0.69	0.23	0.46	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	28.21	20.26	2.82	1.03	2.82	2.31	1.03	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.61	18.05	3.61	0.48	0.72	1.44	0.96	0.24	0.00
ductus deferens, adult	10196-103E7	17.44	15.45	6.48	3.49	1.99	0.00	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	18.72	10.08	2.88	0.00	0.00	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	19.13	8.83	6.62	2.21	1.47	0.74	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	24.86	7.52	6.28	0.83	1.82	0.08	0.58	0.25	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	43.97	13.32	12.44	1.33	3.11	0.67	2.66	0.00	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.91	12.47	5.88	0.57	2.72	0.72	1.15	0.57	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	22.81	22.81	6.17	1.23	0.00	0.00	1.23	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	12.41	18.16	3.63	0.61	0.61	0.30	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	21.92	15.13	3.70	2.16	0.31	0.62	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	30.21	13.13	6.57	3.94	1.31	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	36.87	7.04	7.71	2.35	3.35	0.00	1.68	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	29.18	17.94	4.53	1.27	1.45	0.54	0.72	1.27	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.32	19.78	3.86	0.64	0.80	0.64	0.16	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	11.89	18.90	4.67	0.89	1.00	0.67	0.33	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	27.94	20.02	5.94	1.43	2.31	0.99	1.32	0.55	0.11
epididymis, adult	10197-103E8	17.79	13.40	8.58	1.26	0.84	0.84	0.00	0.21	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	6.74	6.39	2.48	0.89	1.77	0.18	0.35	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.65	7.08	1.18	0.00	0.79	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	17.82	16.51	5.37	3.54	2.36	0.26	0.52	0.26	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	20.96	20.57	7.09	3.15	2.85	0.49	0.30	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	18.26	18.15	4.93	2.80	1.90	0.22	0.90	0.56	0.00
esophagus, adult, pool1	10015-101C6	18.47	14.97	4.57	1.27	0.85	0.42	0.11	0.00	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	36.32	43.21	21.29	1.63	15.65	3.63	4.01	0.38	0.13
eye - muscle inferior rectus, donor1	10272-104E2	31.39	7.24	4.83	0.00	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	8.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	13.39	1.49	7.44	4.46	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	24.08	5.73	4.59	1.15	1.15	1.15	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	27.69	8.74	7.29	0.00	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	25.68	14.24	3.31	1.27	0.76	0.76	0.25	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	15.39	13.46	2.18	0.13	0.90	0.64	0.38	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	8.07	13.53	9.26	1.42	0.95	1.19	0.47	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	26.18	50.48	9.29	2.91	1.88	3.75	1.03	0.38	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	14.41	9.61	3.90	0.00	2.70	0.30	1.20	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	7.86	17.74	1.92	0.73	1.01	0.55	0.18	0.27	0.00
gall bladder, adult	10198-103E9	12.31	11.83	6.76	0.72	0.72	0.48	0.24	0.00	0.97
gamma delta positive T cells, donor1	11937-126A2	45.63	16.64	8.05	3.22	1.61	0.00	1.07	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	38.84	10.46	10.08	2.24	0.75	0.75	0.37	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.25	9.50	2.32	0.42	0.63	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	22.44	14.70	3.87	2.13	0.97	0.39	0.00	0.19	0.58
gastric cancer cell line:AZ521	10549-107H9	24.27	30.17	10.00	1.48	1.97	0.82	0.49	0.49	0.33
gastric cancer cell line:GSS	10560-108A2	15.56	11.90	1.83	0.92	0.00	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	52.77	10.28	3.66	0.91	0.23	0.46	0.46	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	5.28	14.46	2.29	0.57	1.03	0.57	0.92	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	6.44	9.10	1.96	0.70	0.70	0.42	0.42	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	12.47	6.98	5.99	1.50	0.25	0.25	0.50	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	8.55	3.80	3.27	0.21	0.95	0.00	0.74	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.27	3.79	2.95	0.28	1.12	0.00	0.42	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	13.13	15.01	5.08	0.33	4.30	0.66	0.77	0.00	0.00
glioma cell line:GI-1	10413-106B8	15.23	6.44	4.39	0.29	0.00	0.29	1.46	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	17.49	11.66	10.93	1.46	4.37	0.00	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	30.02	36.13	11.23	2.93	2.20	0.98	0.73	0.00	0.49
globus pallidus, adult, donor10258	10367-105F7	47.92	27.38	1.37	0.00	4.11	1.37	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	20.25	11.72	2.13	0.00	1.07	1.60	0.00	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	102.78	19.58	9.79	2.45	2.45	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	12.16	8.64	2.56	0.32	0.32	0.00	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	16.53	23.41	3.21	0.46	1.84	0.00	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	16.00	14.63	5.03	0.46	0.46	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	18.68	12.88	5.15	0.00	0.64	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	23.00	12.94	1.44	0.00	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	28.12	18.52	3.43	0.00	0.00	0.69	1.37	0.00	0.00
hIPS, biol_rep3	14382-156B8	23.17	9.93	7.72	0.00	1.10	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	9.48	18.10	4.31	1.44	0.00	0.00	0.29	0.86	0.00
heart - mitral valve, adult	10205-103F7	9.57	8.97	6.28	1.49	0.90	0.60	0.30	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	14.90	13.34	6.28	0.78	0.26	0.00	0.26	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	6.66	10.82	5.83	3.33	0.83	0.00	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	25.92	20.81	3.47	0.82	0.61	0.41	0.20	0.82	0.00
heart, adult, diseased, donor1	10051-101G6	7.66	6.81	0.00	0.00	1.28	0.00	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	7.82	5.98	5.75	0.23	0.69	0.00	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	24.34	14.17	4.93	0.92	1.75	0.31	0.31	0.00	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.43	10.80	2.47	0.31	0.31	0.00	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	30.92	11.89	10.70	1.19	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.12	18.89	6.08	2.32	3.20	0.66	0.77	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	19.78	18.45	7.04	3.64	3.40	0.49	0.73	0.12	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	16.77	22.53	5.66	2.83	3.74	0.20	1.41	0.40	0.10
hepatoma cell line:Li-7	10484-107A7	20.35	10.57	4.23	1.11	1.56	0.33	0.56	0.78	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	23.72	29.35	3.32	0.90	1.21	0.60	0.50	0.20	0.00
hippocampus - adult, donor10196	10169-103B7	22.71	18.93	1.89	2.84	0.95	0.00	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	21.23	27.55	5.92	4.49	3.27	1.02	1.22	0.00	0.61
hippocampus, adult, donor10258	10374-105G5	11.95	16.43	1.49	0.00	1.00	1.00	0.50	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	21.85	16.21	5.29	1.06	1.41	1.41	0.00	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	43.94	32.96	14.04	4.88	2.44	0.00	1.83	0.61	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	21.40	21.21	7.66	2.95	0.79	1.77	0.98	0.59	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	27.67	24.63	7.87	1.27	1.52	1.02	0.25	0.76	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	18.61	33.83	9.02	1.69	0.00	0.56	1.13	0.00	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	22.72	23.76	12.65	3.61	0.52	1.03	0.26	0.26	5.16
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	18.60	33.79	7.21	1.90	0.00	3.80	0.00	0.00	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	57.51	15.77	7.01	1.46	1.46	2.34	0.00	0.00	5.84
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	61.83	12.49	18.74	1.72	0.65	1.08	0.22	0.00	6.25
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	75.07	13.35	12.51	0.83	1.25	0.83	0.42	0.42	5.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	36.70	9.71	10.42	0.95	1.18	0.71	0.71	0.00	3.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	35.84	10.61	14.30	1.77	0.48	0.64	0.48	0.48	3.54
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	43.76	10.10	17.51	2.02	0.00	0.67	0.00	0.00	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	20.03	21.44	7.98	2.50	0.94	1.41	0.16	0.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	18.67	19.65	9.83	3.93	0.49	0.49	0.49	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	19.20	20.07	11.35	4.36	0.87	0.00	2.62	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	21.19	28.83	14.32	2.86	0.57	0.95	0.19	0.00	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	17.88	21.37	11.34	1.31	0.00	0.87	0.00	0.00	4.80
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	30.99	36.98	7.50	0.50	0.50	1.00	0.00	0.00	8.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	17.71	20.91	8.85	2.83	0.38	0.75	0.19	0.00	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	25.46	18.64	12.73	1.36	0.00	0.00	0.00	0.00	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	28.82	28.50	7.83	0.94	0.63	1.57	0.31	0.00	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.35	10.61	10.94	2.12	0.16	1.14	0.16	0.16	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	22.35	7.84	11.32	2.32	0.58	1.45	0.29	0.00	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	33.48	14.65	10.76	0.30	0.30	0.60	0.00	0.00	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	27.53	12.75	8.87	2.59	1.11	0.55	0.55	0.55	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	24.82	14.83	10.27	3.14	1.43	0.86	0.29	0.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	36.34	26.13	7.35	1.63	1.63	1.63	0.82	0.00	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	23.24	16.55	10.56	2.11	0.35	1.41	0.35	0.00	2.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	20.59	16.79	8.87	1.90	0.63	0.32	0.32	0.00	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	20.28	18.76	7.57	0.30	0.61	1.21	0.00	0.30	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.62	10.86	8.79	1.03	0.52	0.00	0.52	0.00	3.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	26.57	11.29	11.95	1.99	0.00	0.66	0.00	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	22.83	10.26	3.33	0.77	0.77	0.51	0.00	0.00	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.87	6.14	8.69	1.53	0.77	0.51	1.02	0.00	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	30.29	8.33	13.63	1.51	1.51	0.76	0.00	0.00	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	32.26	12.77	8.74	2.02	0.34	1.68	0.00	0.00	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	25.60	16.42	8.69	3.86	0.97	1.21	0.97	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	35.21	25.40	7.13	5.35	0.89	1.78	0.00	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	38.05	23.90	9.76	0.98	1.95	0.98	0.49	0.00	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	15.89	17.42	8.86	4.58	0.61	0.61	0.00	0.00	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	65.06	16.27	3.25	3.25	3.25	0.00	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	19.53	24.16	6.62	1.32	0.33	0.99	0.00	0.00	6.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	37.22	15.87	16.42	1.09	2.74	1.64	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	40.17	17.37	7.24	1.09	1.09	0.36	0.00	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	34.16	8.54	5.69	0.00	0.00	1.07	0.00	0.00	3.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	27.45	10.74	7.16	0.00	0.00	1.19	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	38.19	10.97	10.97	2.71	0.95	1.08	0.41	0.14	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	27.48	9.16	6.73	0.54	0.81	0.54	0.00	0.00	1.35
immature langerhans cells, donor1	11904-125F5	28.09	6.54	2.18	0.24	0.97	0.00	1.21	0.73	0.73
immature langerhans cells, donor2	11905-125F6	47.53	0.79	8.71	0.79	3.96	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	21.48	51.76	8.71	2.27	2.18	3.60	1.32	0.47	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	8.78	12.36	1.95	0.33	0.98	0.65	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	16.32	16.32	4.11	0.80	1.20	0.60	0.50	0.00	0.10
kidney, fetal, pool1	10045-101F9	14.22	14.08	4.60	0.21	1.27	0.85	0.35	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	24.29	39.20	12.36	2.56	1.99	0.99	0.43	0.28	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	9.54	5.94	3.32	0.41	1.38	0.28	0.14	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	27.89	7.71	9.17	1.28	0.92	0.37	0.18	0.00	0.00
left atrium, adult, donor1	10079-102A7	12.53	11.44	1.09	1.09	0.54	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	9.61	7.08	1.01	0.00	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	9.85	16.42	2.19	0.55	0.55	0.00	0.82	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	3.23	6.11	0.72	0.36	0.00	0.36	0.00	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	3.26	6.52	3.80	0.00	0.00	0.00	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	5.83	8.01	1.94	0.73	0.24	0.00	0.24	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	6.27	2.09	1.05	1.05	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	53.01	23.97	7.08	1.06	1.89	0.24	1.06	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	9.69	8.28	1.41	0.16	0.62	0.16	0.31	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	16.57	11.33	2.07	0.37	1.83	0.12	0.37	0.37	0.00
liver, adult, pool1	10018-101C9	11.99	14.42	2.59	0.65	2.59	0.49	0.32	0.16	0.32
liver, fetal, pool1	10086-102B5	8.47	1.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	14.14	15.46	5.83	4.23	1.60	0.58	1.02	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	20.67	21.96	8.12	4.98	1.29	1.11	0.74	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	26.80	12.98	6.77	0.56	0.00	1.41	0.85	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	10.94	13.46	2.52	0.84	2.52	0.42	1.26	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	13.56	8.86	2.77	0.55	2.63	0.14	0.28	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	2.07	6.89	0.69	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.18	9.36	3.16	0.79	0.79	0.13	0.00	0.13	0.00
lung, adult, pool1	10019-101D1	15.36	18.31	5.20	0.95	0.95	0.35	0.47	0.35	0.35
lung, fetal, donor1	10068-101I5	13.13	18.84	5.14	4.85	0.86	0.57	0.57	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	20.62	13.29	3.67	0.46	0.00	0.92	0.46	0.00	0.00
lymph node, adult, donor1	10077-102A5	18.46	12.31	2.84	0.95	0.95	0.47	0.47	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	46.47	16.00	2.63	1.53	0.88	0.66	0.66	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	30.79	8.60	3.32	1.21	1.06	0.45	0.45	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	34.83	29.73	3.40	0.00	1.70	0.00	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	26.20	6.66	4.00	0.89	0.89	0.44	0.00	0.00	0.89
mature adipocyte, donor2	12232-129F9	17.85	11.00	4.15	0.62	1.87	0.42	0.21	0.00	0.62
mature adipocyte, donor3	12233-129G1	13.51	6.40	1.90	0.24	1.66	0.24	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	24.48	12.63	2.11	0.26	1.32	0.00	0.53	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	35.02	16.44	7.62	0.71	0.95	0.71	0.95	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	15.79	31.58	1.13	6.77	0.00	3.38	2.26	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	23.72	34.76	6.07	4.23	2.76	2.02	1.29	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	19.70	30.82	5.40	1.27	0.64	2.54	0.32	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	14.07	20.04	1.28	1.28	1.28	0.43	0.85	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	12.32	30.21	4.89	5.40	2.53	2.36	1.01	0.00	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	22.50	29.07	7.64	5.31	1.49	1.49	1.27	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	17.34	11.56	1.93	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	129.18	43.06	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	20.46	16.87	4.31	2.51	0.00	1.79	1.08	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	16.87	14.93	3.24	0.65	1.30	0.65	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	20.59	28.48	4.64	2.94	2.79	1.08	1.24	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	24.65	26.77	8.33	1.63	1.80	1.22	0.49	0.24	0.00
medulla oblongata, newborn, donor10223	10361-105F1	15.28	13.54	3.12	1.04	1.39	2.78	1.04	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	19.93	21.48	5.09	0.00	1.33	0.89	0.66	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	21.64	18.22	2.57	0.24	0.61	0.12	0.49	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	44.85	10.78	6.76	1.58	1.58	0.29	1.15	0.43	0.29
melanoma cell line:G-361	10465-106H6	12.22	5.97	3.26	1.36	0.27	0.00	1.09	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	5.97	3.44	3.08	0.90	0.18	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	29.08	25.55	10.57	3.52	6.17	0.88	2.64	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	24.37	15.81	15.29	2.59	3.63	0.26	0.78	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	1.69	7.06	3.22	2.76	0.92	0.15	0.15	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	4.73	5.64	3.45	2.54	0.36	0.55	0.73	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	2.07	2.07	2.48	1.24	0.00	0.00	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	2.95	1.69	1.69	2.25	0.42	0.00	0.14	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	5.01	4.62	4.81	3.08	0.58	0.00	0.39	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	3.47	11.80	4.86	0.69	0.00	1.39	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	3.60	4.81	2.23	2.92	1.37	0.00	0.34	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	4.72	3.80	2.19	1.96	0.58	0.00	0.35	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	3.45	3.85	3.18	3.18	0.40	0.13	0.53	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	5.67	3.92	3.78	2.57	0.54	0.27	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	3.70	4.27	2.56	3.27	0.57	0.14	0.85	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.54	15.15	3.29	0.66	0.33	0.66	0.33	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	4.84	5.12	1.94	1.52	0.55	0.14	0.28	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	4.19	10.82	4.89	1.40	0.00	1.40	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1.84	3.67	2.04	3.67	0.00	0.00	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.63	5.75	1.08	1.08	0.36	0.72	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	2.59	3.93	1.55	1.97	0.31	0.10	0.52	0.10	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	5.70	4.79	1.37	0.23	0.23	0.00	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	3.36	3.78	2.10	2.52	0.84	0.42	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	4.93	3.44	4.48	1.79	0.60	0.00	0.45	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	3.41	4.38	3.06	2.01	0.61	0.18	0.61	0.09	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	6.63	6.26	3.68	0.00	0.74	0.37	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	9.44	7.44	3.15	1.14	0.29	0.57	0.86	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	15.16	11.37	1.26	1.26	1.26	0.42	0.84	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	6.39	7.76	1.37	2.28	0.46	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.91	6.91	1.79	0.51	1.02	0.26	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.54	11.52	2.09	0.52	1.05	0.26	0.79	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.70	9.86	1.54	0.62	0.31	0.31	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.00	8.71	3.77	0.94	0.47	0.71	0.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.09	7.11	2.37	0.34	0.68	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6.29	6.29	2.36	0.39	0.00	0.79	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.41	4.63	2.32	0.46	0.00	0.00	0.46	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.94	7.79	1.73	0.00	0.87	0.00	0.29	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.02	9.82	3.12	0.67	0.67	0.67	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	4.57	9.37	2.88	0.72	1.20	0.48	0.48	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	6.60	13.20	2.93	0.00	0.00	0.00	0.00	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	6.38	5.37	2.35	0.34	1.01	0.67	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.09	5.32	2.05	0.41	0.41	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	8.59	8.16	2.58	0.00	1.29	0.86	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	10.94	0.00	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	15.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.17	6.50	1.95	0.32	0.00	0.00	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	4.36	4.36	4.36	0.00	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	10.13	7.46	1.07	1.07	1.07	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	5.72	2.45	1.64	0.00	0.00	0.82	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	6.61	6.61	2.33	0.78	0.78	0.78	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	4.20	6.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	3.97	1.99	0.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.34	5.34	3.56	0.00	0.59	0.59	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	8.53	1.22	3.66	1.22	1.22	0.00	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	4.43	8.23	1.27	0.00	1.27	0.63	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.55	8.28	3.10	0.00	0.69	0.69	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	8.60	4.30	0.00	0.00	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	7.98	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.11	5.70	2.04	0.41	0.41	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	6.36	0.79	0.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	4.13	5.31	2.95	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	6.86	7.17	2.49	0.00	0.00	0.31	0.62	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	6.68	1.34	0.00	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	5.91	2.37	1.18	1.18	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	7.70	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.82	5.51	0.00	0.69	1.38	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.85	4.95	3.46	0.00	1.48	0.49	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	2.24	1.12	1.12	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	5.09	3.18	0.64	1.91	0.00	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.48	2.01	2.42	0.81	0.40	0.00	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	4.36	0.00	0.00	2.18	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	1.27	1.27	0.00	1.27	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.14	3.64	3.64	0.61	1.21	0.00	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	19.77	2.47	3.29	0.00	1.65	0.00	0.00	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.53	6.75	0.79	0.60	0.60	0.60	0.60	0.60	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	5.52	3.89	1.95	0.32	0.65	0.32	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	5.09	2.04	1.02	0.00	0.00	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	25.53	12.38	2.32	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	14.41	12.28	4.49	1.89	0.94	0.24	0.24	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	21.31	6.49	3.48	0.93	0.46	0.46	0.23	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	4.27	4.27	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	12.64	5.65	1.95	0.41	0.72	0.31	0.31	0.10	0.10
mesothelioma cell line:Mero-25	10850-111F4	18.16	5.67	5.67	0.23	0.45	0.23	0.45	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	4.89	7.58	3.91	0.00	0.49	0.00	0.49	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	4.87	8.19	1.77	0.00	0.22	0.22	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	14.72	4.99	4.20	1.05	0.26	0.00	0.26	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	8.68	5.96	2.21	0.17	0.34	0.17	0.17	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	6.82	4.55	1.77	0.00	0.25	0.51	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	8.49	7.04	2.90	0.41	0.21	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	6.63	6.63	4.14	0.00	0.33	0.50	0.33	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	8.14	6.52	2.35	0.18	0.18	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	7.17	3.59	4.78	0.68	1.37	0.34	1.02	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	7.13	3.82	2.29	0.51	0.25	0.25	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	18.27	13.37	7.83	1.63	2.28	0.33	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	10.03	4.61	5.42	0.00	0.81	0.27	0.27	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	6.91	17.27	2.49	0.38	1.15	1.34	0.38	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	10.14	17.95	2.20	0.37	1.10	0.61	0.24	0.24	0.24
migratory langerhans cells, donor3	11903-125F4	8.62	17.77	1.44	0.36	1.79	1.44	0.18	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	21.22	9.47	10.77	4.24	1.63	0.00	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.92	9.75	3.39	1.27	0.42	0.42	0.42	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	43.08	21.88	3.92	0.23	1.38	0.69	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	16.56	8.18	3.23	0.76	2.09	0.00	0.00	0.57	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	29.57	14.41	3.88	1.11	1.29	0.18	0.18	0.00	0.00
myeloma cell line:PCM6	10474-106I6	60.68	15.02	17.79	3.76	2.97	0.20	1.58	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	22.83	9.64	4.57	0.00	0.00	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	34.52	7.65	7.85	0.39	0.39	0.00	0.98	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.25	12.59	3.01	1.56	0.67	0.67	0.33	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.37	11.25	3.24	0.51	0.74	0.74	0.37	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	24.29	11.04	3.86	1.10	0.00	0.55	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	54.98	21.40	16.33	1.15	1.61	1.38	1.15	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	48.27	46.77	13.47	2.81	3.93	0.94	2.06	0.37	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	23.41	10.54	4.01	1.69	0.84	0.00	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	25.90	22.18	7.83	1.12	2.98	0.93	0.37	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	29.65	11.39	4.51	0.71	2.37	0.47	0.24	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	24.39	16.00	4.43	0.32	1.43	0.32	0.32	0.00	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	16.30	9.86	5.23	0.81	1.01	0.20	0.81	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	14.62	8.90	1.91	1.27	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	13.84	8.25	2.40	0.80	0.53	0.53	0.00	0.53	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	46.51	30.61	15.39	0.85	0.51	0.34	0.17	0.00	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	12.81	0.80	0.00	0.80	0.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	19.88	12.50	1.28	1.28	0.64	0.32	0.00	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	12.09	10.77	6.04	1.31	0.53	0.00	0.53	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	26.25	45.65	13.22	1.78	3.37	2.62	1.03	0.37	0.28
occipital cortex - adult, donor10196	10172-103C1	20.60	39.15	4.12	0.00	0.00	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	26.03	29.25	10.20	6.44	2.95	0.81	1.34	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	20.74	21.47	6.91	2.18	1.09	1.46	1.82	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	22.04	34.64	6.82	1.57	1.84	2.10	1.84	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	33.04	29.18	12.01	1.29	1.29	5.58	0.00	0.43	0.43
occipital pole, adult, pool1	10036-101E9	14.19	31.38	8.59	1.66	1.34	2.05	0.63	0.16	0.08
olfactory region, adult	10195-103E6	18.53	26.56	5.92	3.06	0.76	1.53	1.15	0.00	0.19
optic nerve, donor1	10277-104E7	62.03	22.01	18.01	2.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	6.83	10.48	5.70	0.57	0.91	0.80	0.34	0.80	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	12.91	19.10	5.08	0.69	0.55	1.24	0.41	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.58	15.92	2.37	0.34	0.85	0.85	0.51	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	24.60	9.82	4.39	1.27	0.92	0.23	0.69	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	20.28	9.11	6.76	0.59	1.18	0.00	0.29	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	37.37	17.75	16.82	0.93	0.00	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	38.38	8.69	7.63	0.42	1.48	0.00	0.85	0.21	0.00
ovary, adult, pool1	10020-101D2	19.57	18.69	6.81	0.35	0.61	0.87	0.26	0.17	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	25.30	10.82	2.93	0.73	1.10	0.55	0.55	0.18	0.00
pancreas, adult, donor1	10049-101G4	25.40	15.05	1.88	0.94	0.94	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	13.42	3.63	1.40	0.84	0.84	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	11.58	8.35	2.73	0.68	1.02	0.51	0.00	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.07	12.58	1.82	0.17	1.99	0.33	1.16	0.83	0.00
paracentral gyrus, adult, pool1	10035-101E8	23.06	45.94	8.33	2.56	1.56	3.57	1.10	0.64	0.00
parietal cortex, adult, donor10258	10373-105G4	35.23	19.82	2.20	0.73	0.73	2.20	1.47	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	12.23	15.99	0.94	0.94	0.94	2.82	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	17.67	36.77	8.84	4.56	3.14	1.14	1.43	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	18.51	43.88	8.02	1.67	1.59	2.11	1.06	0.53	0.00
parietal lobe, fetal, donor1	10072-101I9	34.91	28.13	5.82	2.91	0.97	2.91	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	15.70	20.19	1.50	1.50	1.12	0.75	0.75	0.00	0.00
parotid gland, adult	10199-103F1	18.50	6.78	3.70	2.47	1.23	0.62	0.00	0.00	0.00
penis, adult	10200-103F2	19.34	16.11	6.98	2.15	1.07	0.54	0.00	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	8.74	2.60	2.05	0.19	0.37	0.19	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	18.07	14.72	3.64	1.02	1.46	0.29	0.15	0.29	0.15
pineal gland - adult, donor10196	10179-103C8	22.58	11.61	2.58	0.00	2.58	0.65	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	48.56	59.22	5.33	2.37	2.37	2.96	1.78	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	31.35	17.56	5.64	0.63	1.88	2.51	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	14.17	32.38	6.07	2.02	2.02	2.02	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	40.65	69.32	5.21	4.69	7.82	3.13	4.17	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	13.62	17.88	1.70	1.70	2.55	3.40	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	36.12	23.54	8.82	1.94	1.51	0.75	0.32	0.22	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	17.75	17.22	5.43	1.46	0.13	0.40	1.06	0.26	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	12.30	5.29	2.33	0.31	0.31	0.16	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	18.85	34.00	9.21	1.98	2.75	2.67	1.64	0.26	0.09
postcentral gyrus, adult, pool1	10032-101E5	14.56	37.14	9.33	2.88	1.48	1.74	0.78	0.09	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	31.37	8.37	4.18	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	27.68	21.85	3.93	1.75	0.87	0.87	0.44	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	30.13	16.34	5.45	1.45	1.82	0.36	0.91	0.18	0.18
prostate, adult, pool1	10022-101D4	15.24	12.42	4.63	0.27	1.45	0.82	0.45	0.18	0.36
putamen, adult, donor10196	10176-103C5	27.62	42.49	9.44	7.32	3.54	0.47	1.42	0.24	0.00
putamen, adult, donor10252	10152-102I8	19.61	17.65	5.88	1.96	0.00	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	12.02	12.02	0.00	0.00	2.19	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	22.47	35.76	3.62	2.90	2.17	0.48	0.00	0.24	0.24
putamen, newborn, donor10223	10365-105F5	13.49	12.74	2.25	0.75	4.50	0.00	2.25	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	17.17	10.47	4.65	1.16	1.16	0.00	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	15.30	13.91	8.35	2.78	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	5.72	8.06	2.76	0.21	1.06	0.21	0.21	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.07	8.28	2.49	0.41	0.00	0.41	0.00	0.41	0.00
retina, adult, pool1	10030-101E3	31.01	15.90	8.85	0.99	1.39	0.99	0.10	0.20	0.00
retinoblastoma cell line:Y79	10475-106I7	24.68	24.94	6.75	1.56	0.26	1.30	0.26	1.04	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	28.65	33.44	7.50	1.97	0.86	1.11	0.25	0.49	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	46.68	18.00	16.59	3.37	1.12	0.84	1.41	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.95	19.70	9.09	1.52	0.00	0.00	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	6.15	9.06	2.10	0.32	0.65	0.49	0.16	0.32	0.00
salivary acinar cells, donor2	11772-123I8	7.16	10.88	2.75	0.14	0.14	0.41	0.55	0.14	0.00
salivary acinar cells, donor3	11773-123I9	13.90	17.21	5.30	0.00	0.66	0.66	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	11.44	8.58	5.15	1.72	1.14	0.00	0.57	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.54	24.53	4.22	1.35	0.08	1.18	1.18	0.84	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	12.93	20.92	4.11	1.41	0.59	1.29	0.82	0.82	0.12
seminal vesicle, adult	10201-103F3	22.22	11.64	7.94	2.65	1.06	0.53	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.49	8.99	2.92	0.24	2.67	0.00	0.49	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	6.29	1.51	0.75	0.00	1.01	0.00	1.01	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	9.03	2.01	0.00	1.00	1.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	11.28	13.16	5.64	2.28	2.01	0.81	1.07	0.54	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	16.69	16.91	4.09	1.55	1.99	0.88	0.77	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	8.52	4.39	2.84	0.52	1.42	0.26	0.77	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	19.86	7.80	4.26	1.42	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	27.95	12.11	4.32	2.16	0.84	0.72	0.12	0.00	0.72
skeletal muscle, fetal, donor1	10066-101I3	11.06	6.03	3.02	0.00	3.02	0.00	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	6.79	20.36	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	17.67	17.67	3.79	1.26	3.16	1.89	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	81.71	32.35	8.00	3.00	2.00	0.67	1.33	0.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	58.63	30.26	8.51	1.89	5.67	0.00	2.52	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	19.66	27.18	10.99	1.35	0.96	1.73	2.12	0.39	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	55.38	9.89	7.09	1.48	2.97	0.33	0.33	0.00	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	6.59	24.13	3.06	0.80	0.64	0.16	0.16	0.16	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	48.38	13.51	6.32	2.40	3.49	0.22	2.62	0.22	0.00
small intestine, adult, pool1	10024-101D6	25.08	16.72	6.57	0.72	1.67	0.24	0.24	0.48	0.12
small intestine, fetal, donor1	10064-101I1	27.76	14.99	2.70	0.25	0.74	0.49	0.00	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.90	15.90	2.05	1.03	1.03	1.03	0.51	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	22.74	18.61	2.58	0.52	0.52	1.03	0.26	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	43.96	19.03	2.95	1.07	1.07	0.54	1.61	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	21.11	11.24	3.67	2.52	3.21	1.15	0.92	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	20.90	20.90	4.34	0.79	3.15	0.39	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	19.37	8.99	5.53	0.00	2.77	1.38	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	33.54	18.30	11.59	0.61	0.61	2.44	0.00	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	16.07	9.64	3.67	0.92	1.84	0.46	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	18.22	14.34	2.09	0.60	1.05	0.15	0.75	0.30	0.00
spleen, adult, pool1	10025-101D7	22.91	18.61	5.73	1.43	3.30	0.77	0.88	0.33	0.22
spleen, fetal, pool1	10044-101F8	14.62	12.55	5.64	1.11	2.15	0.64	0.56	0.48	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	10.25	20.50	3.62	0.83	0.83	0.72	0.41	0.52	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	22.79	13.48	4.94	1.33	0.76	0.19	0.57	0.95	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	46.83	41.93	7.69	1.05	1.75	0.00	1.75	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	26.97	15.64	4.69	0.78	0.39	0.78	0.78	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	15.20	34.56	6.64	2.03	3.83	0.90	1.46	0.45	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	15.25	12.28	2.12	0.42	0.42	0.85	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	13.54	6.77	3.81	0.85	0.00	0.00	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	23.50	11.75	3.20	1.07	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	21.65	12.53	4.56	2.85	2.28	1.14	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	0.00	54.27	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	22.02	23.06	7.06	4.78	2.49	1.25	0.83	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	17.07	12.93	3.10	0.52	1.03	1.03	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	16.96	10.60	1.41	0.00	1.41	0.71	0.71	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	15.36	19.49	6.88	2.29	1.15	1.38	0.00	0.69	0.00
temporal lobe, adult, pool1	10031-101E4	15.34	30.69	5.00	1.19	1.10	1.61	1.19	0.17	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	29.92	27.78	7.12	1.42	1.42	2.85	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	25.05	15.82	8.79	3.08	1.76	2.64	0.44	1.32	0.44
tenocyte, donor1	11763-123H8	11.17	10.12	4.54	1.40	0.00	0.70	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	11.83	9.54	1.91	0.00	0.00	0.38	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	6.30	9.27	2.22	1.85	0.00	0.37	0.37	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	23.79	23.11	4.93	1.19	1.36	0.34	0.17	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	53.03	18.34	9.25	0.77	1.39	0.77	0.46	0.46	0.46
teratocarcinoma cell line:PA-1	10807-111A6	21.70	24.80	7.13	1.39	1.39	0.77	0.15	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	25.01	30.34	6.35	0.89	1.27	1.40	1.02	0.00	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	12.86	17.40	4.92	2.27	1.13	0.76	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	8.51	12.32	6.87	6.11	1.09	0.44	0.44	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	30.29	41.04	4.89	3.26	1.95	2.93	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	38.44	32.10	12.67	2.36	0.75	3.22	1.29	1.93	2.36
testis, adult, pool2	10096-102C6	41.95	36.09	19.40	4.06	1.35	3.16	1.35	1.80	0.00
thalamus - adult, donor10196	10168-103B6	22.08	23.18	7.73	1.10	0.00	1.10	2.21	1.10	0.00
thalamus, adult, donor10252	10154-103A1	29.38	26.26	7.50	4.22	3.59	1.09	0.78	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	9.24	3.08	1.54	0.00	0.00	4.62	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.57	14.49	5.60	1.15	1.65	0.99	0.16	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	16.11	14.38	2.88	0.58	0.58	2.30	1.15	0.00	0.00
throat, adult	10209-103G2	13.98	11.24	9.24	1.00	1.50	0.00	0.50	0.25	0.00
throat, fetal, donor1	10061-101H7	40.83	13.41	2.13	0.91	0.61	0.30	0.00	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	10.73	23.25	7.15	3.18	0.79	0.99	0.79	0.20	0.20
thymus, adult, pool1	10027-101D9	62.73	32.81	14.32	2.49	8.35	1.39	1.59	0.40	0.89
thymus, fetal, pool1	10043-101F7	72.32	30.55	18.60	2.29	6.03	0.52	1.25	0.42	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.81	15.29	7.45	1.46	0.80	0.53	0.27	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	31.99	15.65	4.33	0.28	0.00	0.84	0.42	0.00	0.28
thyroid, adult, pool1	10028-101E1	28.18	8.21	7.37	1.40	0.84	0.19	0.28	0.19	0.37
thyroid, fetal, donor1	10060-101H6	102.56	8.70	6.59	1.58	0.79	1.05	0.00	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	43.11	6.16	3.08	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	13.26	11.16	7.21	0.93	0.70	0.00	0.23	0.00	0.00
tongue, fetal, donor1	10059-101H5	22.46	11.82	1.97	0.39	0.39	0.79	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	28.55	22.84	5.71	1.70	2.40	0.40	0.20	0.20	0.00
trachea, adult, pool1	10029-101E2	15.38	16.93	4.34	0.57	1.80	0.57	0.25	0.16	0.08
trachea, fetal, donor1	10058-101H4	15.77	8.08	0.77	1.54	0.00	0.00	1.15	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	12.05	10.63	4.25	1.77	0.00	0.35	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	24.72	11.04	3.85	0.30	1.93	0.30	0.91	0.30	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	22.88	12.53	5.64	1.41	0.63	0.63	0.47	0.16	0.16
tridermal teratoma cell line:HGRT	10694-109G1	20.93	9.51	5.71	7.61	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	20.06	9.65	2.37	0.34	0.68	0.59	0.08	0.17	0.08
umbilical cord, fetal, donor1	10057-101H3	22.95	14.61	0.00	4.17	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	9.21	11.94	5.80	4.95	0.85	0.85	0.51	0.34	0.17
uterus, fetal, donor1	10055-101H1	12.29	16.38	5.12	3.07	0.51	0.00	0.00	0.00	0.00
vagina, adult	10204-103F6	11.63	13.57	4.52	0.65	1.94	1.29	0.65	0.00	0.65
vein, adult	10191-103E2	13.81	7.23	8.99	3.07	1.10	0.00	0.66	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.55	13.35	2.94	1.60	0.80	0.27	0.00	0.00	0.00